Neddylation (Homo sapiens)

From WikiPathways

Revision as of 14:36, 31 October 2018 by ReactomeTeam (Talk | contribs)
Jump to: navigation, search
3, 4, 7, 8, 10...8, 16, 47, 49, 53...1, 3, 10, 1376737, 70, 718, 16, 47, 53, 67...1, 16, 74, 102, 13719, 74, 83, 116, 1201, 3, 10, 1376, 11, 13, 22, 27...38, 41, 55, 56, 14713, 33, 46, 105, 14612, 17, 24, 35, 65...38, 41, 55, 56, 97...19, 62, 65, 74, 96...1, 10, 10212, 17, 24, 35, 65...14, 19, 49, 64, 74...1, 16, 102, 1378, 16, 47, 53, 67...31, 48, 70, 7118, 22, 40, 90, 92...37, 58, 71, 10020, 21, 28, 39, 50...67, 14812, 17, 20, 25, 26, 42...1, 3, 10, 1377819, 58, 70, 71, 100...63, 7820, 21, 28, 39, 50...12, 17, 25, 26, 42...nucleoplasmcytosolFBXW8 SKP2 WSB1 SPSB2 CUL3 FBXO15 FBXO2 COMMD10 FBXL22 CCDC22 ASB7 UBC(305-380) DDB1 KBTBD8 ASB14 DDA1 ASB5 FBXW5 FBXL20 PSMB10 COMMD2 SPSB4 ASB8 CRLE3ubiquitinligasecomplex:COMMDs:CCDC22:DCUN1DsG76-NEDD8-K689-CUL2 FBXO30 FBXO27 KBTBD8 DCAF7 UBC(305-380) UBE2D1,2,3FBXO32 DCUN1D4 DCUN1D5 FBXL22 COMMD1 FBXO21 ELOC LMO7 DCUN1D2 KLHL21 UBC(1-76) CCDC22 FBXL7 FBXO9 FBXW9 DCAF17 NEDD8 FBXL3 FBXW4 LRRC41 FBXO21 DCAF8 UBE2D1 ASB16 FBXL4 KEAP1 FBXL12 FBXO4 BTRC ASB3 PSMD4 COMMD1 BTBD1 LRRC41 FBXO44 COMMD6 KLHL20 CRL4 E3 ubiquitinligase:CAND1RBX1 UBA52(1-76) ELOC PSMD12 ASB10 COMMD6 SOCS5 FEM1C CAND1 ATPRBBP5 FBXO4 FBXO17 RBX1 COMMD1 PSMB9 ASB8 SOCS2 DDB1 UBD ASB9 C237-UBA3-G76-NEDD8 ASB12 FBXO2 COMMD1 BTRC FEM1C FBXO22 ASB13 ASB4 ASB2 UBE2D2 FBXO11 ASB15 TCEB2 DCUN1D1 PSMB1 ELOC COMMD9 PSMB10 FBXO6 KBTBD7 H2ORBBP5 CUL1 RNF7 (RBX2) PSMD1 FBXL8 DDA1 RBBP7 UBA52(1-76) FBXL3 FBXL13 ASB18 WSB2 ASB12 FBXW12 ASB18 NAE1 TCEB2 CAND1 COMMD4 NEDD8,UBDASB16 FBXL20 G76-NEDD8-K689-CUL2 SOCS3 DCUN1D5 COMMD4 FBXL13 PSMD8 ASB2 FBXO6 CCNF FBXL3 ASB13 FBXW7 CISH TCEB2 G76-NEDD8-K859-CUL4B FBXW9 DDA1 BTRC DCAF17 ASB12 DDB2 FBXW8 DTL PSMA6 26S proteasomeKBTBD7 COMMD5 PSME4 DTL FBXL14 DCUN1D3 COMMD6 CRL1E3ubiquitinligasecomplex:MyrG-DCUN1D3RBBP5 PSME4 COMMD1 COMMD8 RNF7 (RBX2) COMMD10 KBTBD6 PSMD4 COMMD10 LRRC41 RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5DDA1 CUL4A COMMD10 AcM-UBE2MCOMMD10 KLHL20 PSMD11 FBXW9 SPSB2 KCTD7 PSMB1 FBXL8 CUL3 TULP4 DCAF4 SPSB4 FBXW12 FBXO6 UBA3 PPiPSMB4 FBXL13 CCDC22 CUL4B SKP2 GAN FBXO41 COMMD7 WDR5 ERCC8 ERCC8 ASB5 C111-AcM-UBE2M-G76-NEDD8 FBXO6 ASB8 DCUN1D2 LRR1 CUL5 FBXL18 FBXO11 UbhydroxyPro-HIF-alphaCOMMD3 FBXO17 COMMD10 WSB1 G76-NEDD8-K689-CUL2 ELOC ASB11 ZBTB16 COMMD1 UBC(381-456) FBXO15 KLHL2 COMMD2 DCAF7 PSMD14 RBX1 PSME1 LRR1 FBXL8 COMMD9 DCUN1D5 COMMD3 NEURL2 COMMD10 COMMD3 FBXO21 FBXL14 SOCS3 KCTD7 PSMA2 COMMD4 SOCS2 ASB11 COMMD8 UBC(609-684) KLHL3 ASB4 KCTD6 DCUN1D2 FBXO17 FBXL22 SPSB2 UBC(153-228) FBXO10 DCUN1D3 UBB(77-152) FBXO40 FBXO41 FEM1B COMMD5 COMMD8 FBXO44 FBXO31 CUL5 PSMB5 ASB4 CCDC22 SOCS6 PSME3 ASB18 K689-CUL2-G76-NEDD8 RFWD2 COMMD6 ASB6 FBXW2 COMMD10 COMMD8 FBXO4 COMMD1 UBC(77-152) ELOC ANKRD9 WDTC1 FBXL3 ERCC8 PSMD2 UBC(153-228) K720-CUL1-G76-NEDD8 COMMD9 FBXW11 LRRC41 COMMD7 G76-NEDD8-K724-CUL5 ASB5 RBX1 COMMD2 UCHL3,SENP8:NEDD8WSB1 UBC(229-304) KLHL20 FBXL3 FBXL21 CRL E3 ubiquitinligase:CAND1FBXW5 FBXW4 FBXO21 FBXL7 PSMA4 FBXW7 LRR1 COMMD5 COMMD7 DCAF5 ASB6 CUL9 FBXO4 COMMD4 G76-NEDD8-C116-AcM-UBE2F FEM1C DDA1 FBXW2 FBXO21 FBXW9 KCTD7 COMMD7 G76-NEDD8-K689-CUL2 DCAF7 DCAF17 COMMD4 FBXL19 UCHL3 WDR5 FBXL18 UBC(533-608) FBXW4 RNF7 (RBX2) COMMD3 ASB17 LRRC41 CUL2 KLHL13 COMMDs:CCDC22ASB2 DCAF6 ASB7 RBX1 K705-CUL4A-G76-NEDD8 DCUN1D4 COMMD8 NEDD8 ASB9 FBXW4 SPSB4 CCDC22 KLHL42 ASB4 NEDD8(1-88) SKP1 SOCS3 COMMD4 COMMD10 FBXL4 RBX1 DCAF10 DCUN1D2 COMMD3 SPSB4 COPS4 KLHL22 COMMD2 ANKRD9 CCDC22 KLHL22 CUL4A PSMD13 FBXW7 KLHL25 KLHL5 WDR5 COMMD5 DDB1 SHFM1 FBXL19 G76-NEDD8-C237-UBA3 GAN CUL1 RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:hydroxyPro-HIF-alphaFBXW8 COMMD10 FBXO44 FBXO21 COMMD2 SPSB3 ASB6 ASB10 SOCS6 ASB11 FBXW2 COMMD10 FBXL12 FBXW10 CCDC8 CCDC22 SOCS5 CCNF K1881-CUL9-G76-NEDD8 G76-NEDD8-C237-UBA3 FEM1B K720-CUL1-G76-NEDD8 ASB9 SENP8 KLHL21 FBXO30 ASB11 FBXW5 FEM1A SHFM1 KLHL13 ASB1 KLHL2 SKP1 COMMD6 DCAF4 DCUN1D5 SPSB2 FBXL20 PSMB3 COMMD4 COMMD5 COMMD8 CCDC8 C116-AcM-UBE2F-G76-NEDD8 FBXW11 FBXW2 NEDD8-CUL9:RBX1SOCS2 UBB(77-152) UBC(305-380) AcM-UBE2M:NEDD8-UBA3:NAE1:NEDD8FBXO17 ASB16 FBXO27 FBXW9 DCAF7 PSMD6 FBXL12 RBX1 FBXL7 FBXL21 ASB15 COMMD5 FBXW10 FBXL4 FBXO41 ASB15 COMMD9 PSMC3 FBXL21 K724-CUL5-G76-NEDD8 FBXO31 NEDD8 FBXW12 FBXL22 COPS7B FBXL16 UCHL3 RFWD2 C237-UBA3-G76-NEDD8 SPSB1 COMMD7 DCUN1D3 ASB15 GAN COMMD6 FBXL22 FBXW5 AcM-UBE2MKBTBD6 DCUN1D5 CUL1 SPSB4 CUL7 COMMD8 AcM-UBE2M BTRC KLHL42 COMMD8 FBXL21 FBXL14 NEDD8,UBD:NUB1:26SproteasomeASB10 FBXO15 KCTD6 FBXW10 DDB2 DCAF4 ASB3 DCUN1D1 COMMD8 WDTC1 ELOC UBB(153-228) UBC(153-228) FBXW8 FBXL20 DCAF4 DCUN1D5 SPSB3 PSMD6 FBXO4 ASB11 CAND1G76-NEDD8-C111-AcM-UBE2M FBXW5 FBXO32 WSB2 SPSB1 FBXL19 FBXL4 FBXL8 PSMA5 NEURL2 ASB4 ASB15 ATPASB1 FBXO2 COMMD8 PSMA4 CCNF DCAF4 RNF7 (RBX2) CUL4A KLHL9 KLHL5 SPSB3 PSME2 COMMD2 FBXO10 DCUN1D3 C237-UBA3-G76-NEDD8 CISH COPS3 CCDC22 DCAF16 FBXW10 FBXL7 FBXL13 FEM1B COMMD4 COMMD2 COMMD6 BTBD6 FBXL16 DCUN1D2 WSB2 DCAF5 RBX1 C111-AcM-UBE2M-G76-NEDD8 DCAF16 DCUN1D5 ASB13 CUL9 FBXL4 PSME3 COMMD2 KLHL25 FBXL15 KCTD7 COMMD4 RFWD2 ASB6 VHL DDA1 COMMD9 FBXL12 DCUN1D1 FBXL12 COMMD1 FBXL3 FEM1A BTRC SKP2 BTBD6 FBXW11 DCAF10 UBB(1-76) OBSL1 RBX1 ASB7 COMMD6 COMMD3 FBXL8 FBXL3 NUB1-1 COMMD4 COMMD10 DCUN1D3 ASB11 PSMC6 FBXO30 SOCS3 FBXO2 FBXO32 FBXO9 CRL1E3ubiquitinligase:COMMDs:CCDC22PSMA1 NEDD8-CRL4E3ubiquitinligase:COMMDs:CCDC22:DCUN1D1,2,4,5SENP8 DCUN1D4 PUM2 CRL E3 ubiquitinligasesFBXL4 SKP1 UBC(533-608) BTBD6 SOCS5 COMMD8 TULP4 DCAF5 CISH COMMD10 DCAF8 UCHL3,SENP8:NEDD8(1-88)SOCS3 ASB2 NEDD8-AcM-UBE2F:CRL5E3ubiquitinligase:COMMDs:CCDC22:DCUN1DsFBXL5 FBXO4 FBXW12 FBXW12 ASB5 K724-CUL5-G76-NEDD8 TCEB2 KLHL41 FBXO32 ANKRD9 FBXW12 RBX1 ASB18 ub-hydroxyPro-HIF-alpha:VHL:EloB:EloC:NEDD8-CUL2:RBX1:COMMDs:CCDC22:DCUN1D1,2,4,5DCAF13 ASB9 ASB17 UBE2D3 DCUN1D2 FBXL14 PSMA7 FBXW9 CUL1 COMMD1 DCAF6 FEM1B FBXO40 KLHL11 CUL5 FBXW12 CUL5 RBX1 FBXL8 G76-NEDD8-C111-AcM-UBE2M G76-NEDD8-C111-AcM-UBE2M DCUN1D1 FBXO11 DCAF16 SOCS5 DCUN1D2 FBXO27 2xHP-HIF1A FBXO15 DCAF13 ASB3 UBC(457-532) COMMD2 VHL PSMD9 ASB5 PSMD1 PSMA7 FBXW12 UBXN7 DCUN1D2 RFWD2 BTBD1 PSMA8 COPS8 FBXO10 CCDC22 TCEB2 FEM1A FBXL15 UBC(533-608) DCAF11 FBXL5 COMMD1 DCAF6 DCAF6 PSMB2 ASB7 DCAF13 AcM-UBE2F:NEDD8-UBA3:NAE1:NEDD8NEDD8(77-88)COMMD9 FBXW7 PSMB11 FBXO30 K689-CUL2-G76-NEDD8 COMMD2 FBXO10 DCUN1D1 DCUN1D4 C111-AcM-UBE2M-G76-NEDD8 CCDC22 CUL2 FBXO4 FBXL19 KEAP1 COMMD9 SOCS6 COMMD1 FBXO21 ASB17 DCUN1D4 COMMD4 BTBD1 BTRC CUL7 TULP4 DTL SPSB1 FBXO6 FBXL18 FBXL5 LRRC41 G76-NEDD8-C111-AcM-UBE2M COMMD3 DDB1 UCHL3,SENP8SKP1 RBX1 ASB13 PSMA5 CUL4A COPS3 KLHL42 RFWD2 COMMD5 NEDD8 ERCC8 FBXO7 ASB18 K689-CUL2-G76-NEDD8 G76-NEDD8-C237-UBA3 FBXL22 DCUN1D1 PSMC3 DDB2 RBX1 FBXO40 CUL1 NEDD8-AcM-UBE2FSKP1 SPSB2 FEM1B COMMD7 COPS6 SPSB1 FBXO30 NEDD8-CRL1E3ubiquitinligase:COMMDs:CCDC22:DCUN1DsASB10 DCUN1D4 FBXL21 FBXL7 RBBP7 COMMD8 FBXO4 FBXO44 UBA52(1-76) FBXO17 CCNF FBXL4 COMMD10 DCAF11 COMMD4 COMMD5 ASB16 DCAF8 KLHL42 ASB12 FBXL21 BIRC5FBXW8 PSMC5 DCUN1D4 FBXO30 FBXO11 RBX1 ASB16 COMMD3 COPS2 LMO7 FBXW10 SOCS6 ASB11 UBC(77-152) CUL4B FBXO9 PSMD9 SOCS6 COMMD7 ASB3 FBXW4 NEDD8-AcM-UBE2M:CRL1E3ubiquitinligase:COMMDs:CCDC22:DCUN1DsCOMMD10 LRRC41 KLHL25 SOCS5 COMMD6 COP9PSMB9 ZBTB16 FBXO10 RBX1 KLHL3 FBXL22 FBXL19 CAND1GPS1 ASB9 KEAP1 WDR5 COMMD6 ASB18 SKP2 ASB8 NEDD8-AcM-UBE2M:CUL9:RBX1FBXL7 RBX1 ASB16 ZBTB16 FBXO11 NEDD8-AcM-UBE2MFBXL16 ASB2 ASB5 DCUN1D3 mRNAFBXL14 FBXL15 SPSB1 CRL4E3ubiquitinligase:COMMDs:CCDC22FBXO15 FBXO9 FBXL13 ASB1 G76-NEDD8-K724-CUL5 FBXO22 COMMD2 VHL FBXO40 BTBD1 FBXO9 KBTBD7 RNF7 (RBX2) FBXO40 COMMD10 PSMB7 2xHP-HIF1A FBXL16 FBXO30 RPS27A(1-76) PSMC2 FBXW4 COMMD2 COMMD5 COMMD6 FBXO21 FBXL5 VHL SOCS2 PSMF1 COMMD9 PSMD11 DCAF8 COMMD7 ASB14 DCUN1D1,2,4,5DCUN1D3 WSB1 COMMD3 AcM-UBE2F ASB1 COMMD1 RNF7 (RBX2) COMMD6 C237-UBA3-G76-NEDD8 PUM2:DCUN1D3 mRNAKBTBD13 FBXO31 KLHL41 FBXO6 DCUN1D2 WSB2 KBTBD8 DCUN1D2 PSMD10 FBXW8 COMMD6 DCUN1DsKLHL22 NEDD8 TCEB2 DCAF5 FBXO31 HP-HIF3A COMMD2 FBXW2 FBXO2 FBXO15 ASB8 COMMD6 ASB12 ASB8 ELOC UBC(457-532) COMMD7 FBXO7 PSMA2 FEM1A KCTD7 FBXO9 KBTBD6 PSMA3 G76-NEDD8-K720-CUL1 CISH SOCS5 KBTBD13 DCUN1D1 ASB7 NUB1DCAF17 FBXO17 NAE1 COMMD3 SOCS2 FBXL18 TULP4 COMMD4 DCAF7 SOCS5 FBXO7 CRLE3ubiquitinligase:COMMDs:CCDC22DCAF6 DCAF7 VHL FBXL12 PSMB7 DCUN1D4 RPS27A(1-76) KLHL21 FBXL13 DTL KCTD6 LRR1 UBB(77-152) COMMD4 CCNF FBXL15 PSMA3 2xHP-HIF1A COMMD9 FBXO22 LMO7 FBXO17 UBC(229-304) FBXO44 CUL4A ASB12 FEM1C UBC(1-76) NEDD8CRLE3ubiquitinligases:COMMDs:CCDC22:DCUN1DsFBXW10 FBXO6 RNF7 (RBX2) FBXW9 ASB1 FBXO6 WSB1 FBXL7 FBXL20 FBXL7 K1881-CUL9-G76-NEDD8 COMMD2 CCNF FBXO44 WDR5 COPS5 ASB3 G76-NEDD8-K1881-CUL9 SKP1 KLHL22 ASB14 FBXL16 COMMD9 BTBD6 COMMD6 FBXL19 SPSB3 COMMD7 DCUN1D2 TULP4 COMMD4 ASB12 PSMB5 FBXO27 PSMB8 DCUN1D4 TULP4 KBTBD13 FBXL16 ASB18 COMMD8 FBXO27 SKP2 UBD COMMD7 CCNF KLHL13 FBXL5 FBXW5 FBXL5 ELOC DCAF11 RBBP5 COMMD5 COMMD8 ASB15 BTRC ASB14 FBXW11 FBXO2 DCAF10 TCEB2 NAE1 COMMD8 COMMD3 NEDD8-AcM-UBE2M:CRL4E3ubiquitinligase:COMMDs:CCDC22:DCUND1,2,4,5SKP2 FBXO44 KLHL21 COMMD1 CUL7:CCDC8:OBSL1CUL3 ub-BIRC5FBXW11 RBX1 DCUN1D5 ASB17 CCDC22 COMMD7 KLHL5 ASB5 RBX1 DCAF16 BTRC COMMD6 DCAF10 DCAF17 FBXL20 HP-HIF3A WSB1 ASB14 G76-NEDD8-C116-AcM-UBE2F FBXW4 FBXL21 C111-AcM-UBE2M-G76-NEDD8 NEDD8-AcM-UBE2MFBXO41 FBXL22 COPS2 KCTD6 FBXL14 UBXN7FBXL21 PSMD10 UBC(77-152) KLHL13 KLHL42 UBC(609-684) COMMD6 KLHL3 ASB17 UBE2D2 DCAF16 GPS1 COMMDs:CCDC22COMMD4 FEM1C CCNF WSB2 FBXL14 RBX1 NEDD8-CUL9:RBX1:CUL7:CCDC8:OBSL1FBXL8 KLHL41 SPSB4 LMO7 UBB(1-76) FBXW12 ASB16 COPS7A FBXO31 RBBP5 FBXO31 FBXO7 CCDC22 TCEB2 G76-NEDD8-K705-CUL4A COMMD2 ASB6 LMO7 ASB10 ELOC FBXW9 ANKRD9 SPSB3 ASB9 COPS5 DDB1 PSMD8 FBXO40 DCUN1D1 DCAF11 FBXO7 ELOC DCAF13 COMMD9 SOCS2 WDTC1 CCDC22 COMMD2 ANKRD9 LRRC41 FBXO32 WDTC1 NUB1-2 TCEB2 DCUN1D4 PSMD3 2xHP-EPAS1 PSMD12 G76-NEDD8-K689-CUL2 COMMD5 FBXO9 WDR5 ASB17 FBXO22 CCDC22 COP9 signalosomeDCAF8 COMMD2 DCUN1D5 WDTC1 COPS6 FBXO30 COMMD8 KLHL2 FBXO22 ASB8 TCEB2 CUL4B KEAP1 ASB16 FBXW8 SKP1 PSMC4 KLHL13 KLHL41 DCAF13 FBXW10 COMMD7 FBXO27 SKP1 2xHP-EPAS1 CRL4E3ubiquitinligase:COMMDs:CCDC22:DCUN1D1,2,4,5COMMD1 BTBD1 ASB3 DCUN1D2 DCAF8 NEDD8COMMD8 ASB17 FBXL13 COMMD5 K859-CUL4B-G76-NEDD8 LRR1 COMMD3 ZBTB16 ASB1 RBX1 FBXW8 CUL4B KBTBD13 FBXL16 LMO7 PSMC1 COMMD9 SPSB2 PSMD7 COMMD9 KBTBD7 FBXO2 PSMC2 COMMD9 COMMD10 UBB(1-76) DTL FBXO30 ASB13 FBXW7 FBXO17 OBSL1 COMMD7 DCUN1D2 PSMC6 FBXW10 CCDC22 UBE2D1,2,3:UbiquitinFBXW11 ASB11 SOCS2 ASB1 FBXO44 FBXO41 ASB13 ASB6 ANKRD9 FBXL14 DCAF11 COMMD5 FBXO10 FBXW7 C116-AcM-UBE2F-G76-NEDD8 COMMD5 SPSB1 PSMD2 COPS7A PSMB6 FBXL18 ASB14 DCUN1D1 FBXL18 G76-NEDD8-C111-AcM-UBE2M COMMD5 CCDC22 KBTBD6 FBXL8 ASB3 COMMD4 CISH FBXO40 COMMD3 COMMD3 SOCS6 PSME1 FBXL5 DCUN1D3 mRNA FBXL16 FBXL18 COMMD8 COMMD10 DCAF6 DCUN1D4 COMMD9 FBXO7 DCUN1D1 FBXL20 COMMD1 SPSB2 TULP4 UBA3:NAE1DCUN1D5 KEAP1 NEDD8FBXL19 DCAF4 KLHL2 WSB2 FBXO2 KLHL41 COMMD10 FBXL15 WDTC1 ASB12 FBXO11 PSMD13 FBXL16 KLHL5 COPS4 UCHL3 UBC(229-304) FBXL15 DCUN1D5 COMMD9 FBXO40 COMMD5 FBXW11 FBXO22 PSMB4 PSMA6 FBXW5 ERCC8 SOCS5 COMMD4 UBB(153-228) FBXL5 CCDC22 FBXW4 FBXO7 NEDD8-CRL5E3ubiquitinligase:COMMDs:CCDC22:DCUN1DsFBXO32 RPS27A(1-76) FBXL20 FBXO2 FBXW11 UBE2D1 COMMD7 COMMD3 DCUN1D4 FBXW9 ZBTB16 COMMD1 RBBP7 FBXO40 KLHL20 CUL2 RBX1:CUL4:DDB1:DCAFsFBXL13 SOCS3 FBXO6 FBXL14 DCUN1D1 ASB10 FBXW10 SPSB2 SOCS3 FBXL22 DCUN1D4 NUB1-1 DCUN1D5 ASB10 DCAF16 KBTBD13 DCAF11 CISH FBXO27 ASB15 NEURL2 COMMD10 FBXL19 FBXL15 COMMD8 DCUN1D5 G76-NEDD8-K712-CUL3 NEDD8 NEURL2 COMMD6 FBXO9 VHL ASB2 DCAF10 FBXO17 NAE1 FEM1A ASB4 COMMD5 FBXW5 FBXO7 FBXL15 COPS8 CUL5 KLHL11 COMMD9 DCAF13 SPSB3 G76-NEDD8-K720-CUL1 FBXO41 UBC(381-456) COMMD7 ASB17 DCUN1D5 FBXO10 CCDC22 K712-CUL3-G76-NEDD8 K689-CUL2-G76-NEDD8 COMMD3 COMMD4 FBXW11 NEURL2 ASB2 CUL5 COMMD2 BTBD6 DTL PSMA1 KLHL3 COMMD7 PSMD7 FBXL3 DDB2 RBBP7 ASB14 FBXO32 FBXO7 CISH FBXL8 RBBP7 CUL9:RBX1SKP2 SKP2 PSME2 FBXO27 KLHL25 AcM-UBE2FCRL5E3ubiquitinligase:COMMDs:CCDC22SOCS6 ASB1 FBXL13 FBXO41 FBXL12 FBXO31 COMMD4 G76-NEDD8-C237-UBA3 CCDC22 UBE2D3 VHL COMMD2 KLHL9 PSMC1 KBTBD7 ELOC SOCS6 C111-AcM-UBE2M-G76-NEDD8 RBX1 NEURL2 FBXO22 KLHL20 KLHL11 ASB8 COMMD8 ASB7 RBBP5 DCAF10 FBXO11 FBXO15 FBXW4 FBXW2 LMO7 COMMD7 SPSB4 FBXO31 G76-NEDD8-K1881-CUL9 ASB7 ASB18 PSMD5 COMMD3 FBXL12 FBXO11 PSMB8 FBXW2 FBXW2 ASB2 WSB2 CISH COMMD3 UBC(1-76) DCUN1D2 ASB5 PSMB3 CUL3 ASB3 KLHL25 DCUN1D1 ASB13 FBXO4 COPS7B FBXO31 FBXL19 COMMD9 DCUN1D1 COMMD2 TULP4 COMMD7 DCAF5 KLHL9 UBB(153-228) ANKRD9 CUL1 MyrG-DCUN1D3ASB10 ASB6 UBC(609-684) COMMD5 KLHL5 KCTD6 DCUN1D5 FBXL5 PSMD14 DCUN1D1 COMMD6 PSMD5 FBXL4 PSMD3 COMMD5 DDB2 SOCS2 RBX1 NUB1-2 FBXO44 FBXW2 KBTBD6 KBTBD8 DCUN1D2 KBTBD8 COMMD3 COMMD1 FBXL18 FBXO27 DCAF17 DCUN1D1 KLHL9 SKP2 NEDD8-UBA3:NAE1:NEDD8SPSB1 FBXL21 BTRC FBXO22 ERCC8 FBXW5 FBXL3 HP-HIF3A LMO7 RBBP7 DDB1 WSB1 UBC(457-532) FBXO15 COMMD1 PSMB6 PSMC5 COMMD6 FBXW8 FBXW7 VHL LMO7 FBXO9 DCUN1D3 SOCS3 WSB2 ASB9 RFWD2 DCAF5 COMMD1 CUL4B ASB4 ASB14 FBXO32 AMPDCUN1D4 FBXO41 PSMB11 FBXL18 KLHL22 FBXO41 2xHP-EPAS1 CCDC22 COMMD5 KLHL11 FBXL7 CUL1 NAE1 FBXO21 RBX1 FBXO22 ASB6 GAN WSB1 ANKRD9 VHL COMMD7 SKP1 TCEB2 KLHL21 FBXO11 SPSB1 ASB7 FBXO15 FBXO32 DCUN1D4 SPSB4 KLHL11 DDB2 ASB4 K689-CUL2-G76-NEDD8 FBXO10 CCNF TCEB2 FBXL4 ASB13 ASB9 PSMF1 FBXL15 KLHL2 ELOC FBXO10 COMMD9 PSMC4 FBXW7 NEURL2 SPSB3 NEURL2 COMMD3 PSMA8 MyrG-DCUN1D3 UBC(381-456) GAN CUL2 COMMD9 RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:UBXN7FBXL20 KLHL3 NEDD8-UBA3:NAE1KLHL9 SPSB3 SENP8 ASB15 RNF7 (RBX2) COMMD1 FBXW7 PSMB2 FBXL12 791149157, 1287957, 12811057, 12879130861238282109513057, 12826110961114911396111476251308228257, 1288857, 12879869, 99, 1191091099, 99, 11913913213936130110582792515113230, 34613613976798636828257, 12811051132822212361139519, 99, 11911461515132767910911461130519, 99, 1191141326191, 931301093679132576619, 99, 119616, 603657, 1287911013282611143651391395113076213951257, 12813251586109130251091098613211011451114


Description

NEDD8 is a small ubiquitin-like molecule that is conjugated to substrate proteins through an E1 to E3 enzyme cascade similar to that for ubiquitin. The best characterized target of neddylation is the cullin scaffold subunit of cullin-RING E3 ubiquitin ligases (CRLs), which themselves target numerous cellular proteins for degradation by the proteasome (Hori et al, 1999; reviewed in Soucy et al, 2010; Lyedeard et al, 2013). The multisubunit CRL complexes are compositionally diverse, but each contains a scaffolding cullin protein (CUL1, 2, 3, 4A, 4B, 5, 7 or 9) and a RING box-containing E3 ligase subunit RBX, along with other adaptor and substrate-interacting subunits. RBX2 (also known as RNF7) interacts preferentially with CUL5, while RBX1 is the primary E3 for most other cullin family members (reviewed in Mahon et al, 2014). Neddylation of the cullin subunit increases the ubiquitination activity of the CRL complex (Podust et al, 2000; Read et al, 2000; Wu et al, 2000; Kawakami et al, 2001; Ohh et al, 2002; Yu et al, 2015). In addition to CRL complexes, a number of other less-well characterized NEDD8 targets have been identified. These include other E3 ubiquitin ligases such as SMURF1 and MDM2, receptor tyrosine kinases such as EGFR and TGF beta RII, and proteins that contribute to transcriptional regulation, among others (Xie et al, 2014; Watson et al, 2010; Oved et al, 2006; Zuo et al, 2013; Xirodimas et al, 2004; Singh et al, 2007; Abida et al, 2007; Liu et al 2010; Watson et al, 2006; Loftus et al, 2012; Aoki et al, 2013; reviewed in Enchev et al, 2015).
Like ubiquitin, NEDD8 undergoes post-translational processing to generate the mature form. UCHL3- or SENP8-mediated proteolysis removes the C-terminal 5 amino acids of NEDD8, generating a novel C-terminal glycine residue for conjugation to the cysteine residues in the E1, E2 enzymes or lysine residues in the substrate protein, usually the E3 NEDD8 ligase itself (Wada et al, 1998; reviewed in Enchev et al, 2015). Most substrates in vivo appear to be singly neddylated on one or more lysine residues, but NEDD8 chains have been formed on cullin substrates in vitro and on histone H4 in cultured human cells after DNA damage (Jones et al, 2008; Ohki et al, 2009; Xirodimas et al, 2008; Jeram et al, 2010; Ma et al, 2013; reviewed in Enchev et al, 2015). The significance of NEDD8 chains is still not clear.
NEDD8 has a single heterodimeric E1 enzyme, consisting of NAE1 (also known as APPBP1) and UBA3, and two E2 enzymes, UBE2M and UBE2F, which are N-terminally acetylated (Walden et al, 2003; Bohnsack et al, 2003; Huang et al, 2004; Huang et al, 2005; Huang et al, 2009; Scott et al, 2011a; Monda et al, 2013; reviewed in Enchev et al, 2015). All NEDD8 E3 enzymes reported to date also function as E3 ubiquitin ligases, and most belong to the RING domain class. The best characterized NEDD8 E3 enzymes are the CRL complexes described above. RBX1-containing complexes interact preferentially with UBE2M, while UBE2F is the E2 for RBX2-containing complexes (Huang et al, 2009; Monda et al, 2013).
Neddylation is regulated in vivo by interaction with DCUN1D proteins (also called DCNLs). The 5 human DCUN1D proteins interact both with cullins and with the NEDD8 E2 proteins and thereby increase the kinetic efficiency of neddylation (Kurz et al, 2005; Kurz et al, 2008; Scott et al, 2010; Scott et al, 2011a; Scott et al, 2014; Monda et al, 2013). Glomulin (GLMN) is another regulator of CRL function that binds to the neddylated cullin and competitively inhibits interaction with the ubiquitin E2 enzyme (Arai et al, 2003; Tron et al, 2012; Duda et al, 2012; reviewed in Mahon et al, 2014).
The multisubunit COP9 signalosome is the only cullin deneddylase, while SENP8 (also known as DEN1) contributes to deneddylation of other non-cullin NEDD8 targets (Cope et al, 2002; Emberley et al, 2012; Chan et al, 2008; Wu et al, 2003; reviewed in Wei et al, 2008; Enchev et al, 2015). In the deneddylated state, cullins bind to CAND1 (cullin associated NEDD8-dissociated protein1), which displaces the COP9 signalosome and promotes the exchange of the ubiquitin substrate-specific adaptor. This allows CRL complexes to be reconfigured to target other subtrates for ubiquitination (Liu et al, 2002; Schmidt et al, 2009; Pierce et al, 2013; reviewed in Mahon et al, 2014).

View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 8951664
Reactome-version 
Reactome version: 61
Reactome Author 
Reactome Author: Rothfels, Karen

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Huang DT, Miller DW, Mathew R, Cassell R, Holton JM, Roussel MF, Schulman BA.; ''A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8.''; PubMed Europe PMC Scholia
  2. Li Z, Pei XH, Yan J, Yan F, Cappell KM, Whitehurst AW, Xiong Y.; ''CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity.''; PubMed Europe PMC Scholia
  3. Nikolaev AY, Li M, Puskas N, Qin J, Gu W.; ''Parc: a cytoplasmic anchor for p53.''; PubMed Europe PMC Scholia
  4. Watson IR, Blanch A, Lin DC, Ohh M, Irwin MS.; ''Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.''; PubMed Europe PMC Scholia
  5. Tanaka T, Kawashima H, Yeh ET, Kamitani T.; ''Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L.''; PubMed Europe PMC Scholia
  6. Olma MH, Roy M, Le Bihan T, Sumara I, Maerki S, Larsen B, Quadroni M, Peter M, Tyers M, Pintard L.; ''An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases.''; PubMed Europe PMC Scholia
  7. Boh BK, Smith PG, Hagen T.; ''Neddylation-induced conformational control regulates cullin RING ligase activity in vivo.''; PubMed Europe PMC Scholia
  8. Scott DC, Rhee DY, Duda DM, Kelsall IR, Olszewski JL, Paulo JA, de Jong A, Ovaa H, Alpi AF, Harper JW, Schulman BA.; ''Two Distinct Types of E3 Ligases Work in Unison to Regulate Substrate Ubiquitylation.''; PubMed Europe PMC Scholia
  9. Saha A, Deshaies RJ.; ''Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.''; PubMed Europe PMC Scholia
  10. Huang DT, Hunt HW, Zhuang M, Ohi MD, Holton JM, Schulman BA.; ''Basis for a ubiquitin-like protein thioester switch toggling E1-E2 affinity.''; PubMed Europe PMC Scholia
  11. Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, Pause A.; ''Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.''; PubMed Europe PMC Scholia
  12. Min KW, Hwang JW, Lee JS, Park Y, Tamura TA, Yoon JB.; ''TIP120A associates with cullins and modulates ubiquitin ligase activity.''; PubMed Europe PMC Scholia
  13. Tron AE, Arai T, Duda DM, Kuwabara H, Olszewski JL, Fujiwara Y, Bahamon BN, Signoretti S, Schulman BA, DeCaprio JA.; ''The glomuvenous malformation protein Glomulin binds Rbx1 and regulates cullin RING ligase-mediated turnover of Fbw7.''; PubMed Europe PMC Scholia
  14. Hannah J, Zhou P.; ''Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B.''; PubMed Europe PMC Scholia
  15. Read MA, Brownell JE, Gladysheva TB, Hottelet M, Parent LA, Coggins MB, Pierce JW, Podust VN, Luo RS, Chau V, Palombella VJ.; ''Nedd8 modification of cul-1 activates SCF(beta(TrCP))-dependent ubiquitination of IkappaBalpha.''; PubMed Europe PMC Scholia
  16. Emberley ED, Mosadeghi R, Deshaies RJ.; ''Deconjugation of Nedd8 from Cul1 is directly regulated by Skp1-F-box and substrate, and the COP9 signalosome inhibits deneddylated SCF by a noncatalytic mechanism.''; PubMed Europe PMC Scholia
  17. Liu J, Furukawa M, Matsumoto T, Xiong Y.; ''NEDD8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases.''; PubMed Europe PMC Scholia
  18. Cai W, Yang H.; ''The structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functions.''; PubMed Europe PMC Scholia
  19. Nara H, Onoda T, Rahman M, Araki A, Juliana FM, Tanaka N, Asao H.; ''Regulation of interleukin-21 receptor expression and its signal transduction by WSB-2.''; PubMed Europe PMC Scholia
  20. Wei SJ, Williams JG, Dang H, Darden TA, Betz BL, Humble MM, Chang FM, Trempus CS, Johnson K, Cannon RE, Tennant RW.; ''Identification of a specific motif of the DSS1 protein required for proteasome interaction and p53 protein degradation.''; PubMed Europe PMC Scholia
  21. Soucy TA, Dick LR, Smith PG, Milhollen MA, Brownell JE.; ''The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy.''; PubMed Europe PMC Scholia
  22. Meyer-Schaller N, Chou YC, Sumara I, Martin DD, Kurz T, Katheder N, Hofmann K, Berthiaume LG, Sicheri F, Peter M.; ''The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes.''; PubMed Europe PMC Scholia
  23. Scott DC, Monda JK, Bennett EJ, Harper JW, Schulman BA.; ''N-terminal acetylation acts as an avidity enhancer within an interconnected multiprotein complex.''; PubMed Europe PMC Scholia
  24. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, Koepp DM, Elledge SJ, Pagano M, Conaway RC, Conaway JW, Harper JW, Pavletich NP.; ''Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.''; PubMed Europe PMC Scholia
  25. Ohki Y, Funatsu N, Konishi N, Chiba T.; ''The mechanism of poly-NEDD8 chain formation in vitro.''; PubMed Europe PMC Scholia
  26. Lange S, Perera S, Teh P, Chen J.; ''Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover.''; PubMed Europe PMC Scholia
  27. Denti S, Fernandez-Sanchez ME, Rogge L, Bianchi E.; ''The COP9 signalosome regulates Skp2 levels and proliferation of human cells.''; PubMed Europe PMC Scholia
  28. Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies RJ.; ''Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1.''; PubMed Europe PMC Scholia
  29. Ma T, Chen Y, Zhang F, Yang CY, Wang S, Yu X.; ''RNF111-dependent neddylation activates DNA damage-induced ubiquitination.''; PubMed Europe PMC Scholia
  30. Zuo W, Huang F, Chiang YJ, Li M, Du J, Ding Y, Zhang T, Lee HW, Jeong LS, Chen Y, Deng H, Feng XH, Luo S, Gao C, Chen YG.; ''c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor.''; PubMed Europe PMC Scholia
  31. Abida WM, Nikolaev A, Zhao W, Zhang W, Gu W.; ''FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity.''; PubMed Europe PMC Scholia
  32. Lewis MD, Roberts BJ.; ''Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein.''; PubMed Europe PMC Scholia
  33. Wu S, Zhu W, Nhan T, Toth JI, Petroski MD, Wolf DA.; ''CAND1 controls in vivo dynamics of the cullin 1-RING ubiquitin ligase repertoire.''; PubMed Europe PMC Scholia
  34. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR.; ''The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner.''; PubMed Europe PMC Scholia
  35. Bohnsack RN, Haas AL.; ''Conservation in the mechanism of Nedd8 activation by the human AppBp1-Uba3 heterodimer.''; PubMed Europe PMC Scholia
  36. Sugasawa K.; ''The CUL4 enigma: culling DNA repair factors.''; PubMed Europe PMC Scholia
  37. Harada JN, Shevchenko A, Shevchenko A, Pallas DC, Berk AJ.; ''Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery.''; PubMed Europe PMC Scholia
  38. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA.; ''Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation.''; PubMed Europe PMC Scholia
  39. Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG.; ''HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.''; PubMed Europe PMC Scholia
  40. Kurz T, Chou YC, Willems AR, Meyer-Schaller N, Hecht ML, Tyers M, Peter M, Sicheri F.; ''Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation.''; PubMed Europe PMC Scholia
  41. Yu C, Mao H, Novitsky EJ, Tang X, Rychnovsky SD, Zheng N, Huang L.; ''Gln40 deamidation blocks structural reconfiguration and activation of SCF ubiquitin ligase complex by Nedd8.''; PubMed Europe PMC Scholia
  42. D'Angiolella V, Donato V, Vijayakumar S, Saraf A, Florens L, Washburn MP, Dynlacht B, Pagano M.; ''SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation.''; PubMed Europe PMC Scholia
  43. Aoki I, Higuchi M, Gotoh Y.; ''NEDDylation controls the target specificity of E2F1 and apoptosis induction.''; PubMed Europe PMC Scholia
  44. Bonicalzi ME, Groulx I, de Paulsen N, Lee S.; ''Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein.''; PubMed Europe PMC Scholia
  45. Loftus SJ, Liu G, Carr SM, Munro S, La Thangue NB.; ''NEDDylation regulates E2F-1-dependent transcription.''; PubMed Europe PMC Scholia
  46. Jones J, Wu K, Yang Y, Guerrero C, Nillegoda N, Pan ZQ, Huang L.; ''A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins.''; PubMed Europe PMC Scholia
  47. Sang Y, Yan F, Ren X.; ''The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications.''; PubMed Europe PMC Scholia
  48. Maine GN, Burstein E.; ''COMMD proteins: COMMing to the scene.''; PubMed Europe PMC Scholia
  49. Maine GN, Mao X, Komarck CM, Burstein E.; ''COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.''; PubMed Europe PMC Scholia
  50. Hipp MS, Raasi S, Groettrup M, Schmidtke G.; ''NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation.''; PubMed Europe PMC Scholia
  51. Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, Scott DC, Borg LA, Neale G, Murray PJ, Roussel MF, Schulman BA.; ''E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification.''; PubMed Europe PMC Scholia
  52. Goldenberg SJ, Cascio TC, Shumway SD, Garbutt KC, Liu J, Xiong Y, Zheng N.; ''Structure of the Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the assembly of the multisubunit cullin-dependent ubiquitin ligases.''; PubMed Europe PMC Scholia
  53. Lee J, Zhou P.; ''DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase.''; PubMed Europe PMC Scholia
  54. Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D.; ''Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.''; PubMed Europe PMC Scholia
  55. Gutierrez GJ, Ronai Z.; ''Ubiquitin and SUMO systems in the regulation of mitotic checkpoints.''; PubMed Europe PMC Scholia
  56. Kim AY, Bommeljé CC, Lee BE, Yonekawa Y, Choi L, Morris LG, Huang G, Kaufman A, Ryan RJ, Hao B, Ramanathan Y, Singh B.; ''SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation.''; PubMed Europe PMC Scholia
  57. Podust VN, Brownell JE, Gladysheva TB, Luo RS, Wang C, Coggins MB, Pierce JW, Lightcap ES, Chau V.; ''A Nedd8 conjugation pathway is essential for proteolytic targeting of p27Kip1 by ubiquitination.''; PubMed Europe PMC Scholia
  58. Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP.; ''Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity.''; PubMed Europe PMC Scholia
  59. Schmidt MW, McQuary PR, Wee S, Hofmann K, Wolf DA.; ''F-box-directed CRL complex assembly and regulation by the CSN and CAND1.''; PubMed Europe PMC Scholia
  60. Peth A, Berndt C, Henke W, Dubiel W.; ''Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability.''; PubMed Europe PMC Scholia
  61. Watanabe Y.; ''Temporal and spatial regulation of targeting aurora B to the inner centromere.''; PubMed Europe PMC Scholia
  62. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH.; ''Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.''; PubMed Europe PMC Scholia
  63. Franz J, Jerome J, Lear T, Gong Q, Weathington NM.; ''The Human IL-22 Receptor Is Regulated through the Action of the Novel E3 Ligase Subunit FBXW12, Which Functions as an Epithelial Growth Suppressor.''; PubMed Europe PMC Scholia
  64. Watanabe K, Yumimoto K, Nakayama KI.; ''FBXO21 mediates the ubiquitylation and proteasomal degradation of EID1.''; PubMed Europe PMC Scholia
  65. Xirodimas DP, Sundqvist A, Nakamura A, Shen L, Botting C, Hay RT.; ''Ribosomal proteins are targets for the NEDD8 pathway.''; PubMed Europe PMC Scholia
  66. Enchev RI, Scott DC, da Fonseca PC, Schreiber A, Monda JK, Schulman BA, Peter M, Morris EP.; ''Structural basis for a reciprocal regulation between SCF and CSN.''; PubMed Europe PMC Scholia
  67. Gong L, Yeh ET.; ''Identification of the activating and conjugating enzymes of the NEDD8 conjugation pathway.''; PubMed Europe PMC Scholia
  68. Gummlich L, Rabien A, Jung K, Dubiel W.; ''Deregulation of the COP9 signalosome-cullin-RING ubiquitin-ligase pathway: mechanisms and roles in urological cancers.''; PubMed Europe PMC Scholia
  69. Mahon C, Krogan NJ, Craik CS, Pick E.; ''Cullin E3 ligases and their rewiring by viral factors.''; PubMed Europe PMC Scholia
  70. Wang X, Newkirk RF, Carre W, Ghose P, Igobudia B, Townsel JG, Cogburn LA.; ''Regulation of ANKRD9 expression by lipid metabolic perturbations.''; PubMed Europe PMC Scholia
  71. Schmidtke G, Aichem A, Groettrup M.; ''FAT10ylation as a signal for proteasomal degradation.''; PubMed Europe PMC Scholia
  72. Hori T, Osaka F, Chiba T, Miyamoto C, Okabayashi K, Shimbara N, Kato S, Tanaka K.; ''Covalent modification of all members of human cullin family proteins by NEDD8.''; PubMed Europe PMC Scholia
  73. Watson IR, Li BK, Roche O, Blanch A, Ohh M, Irwin MS.; ''Chemotherapy induces NEDP1-mediated destabilization of MDM2.''; PubMed Europe PMC Scholia
  74. Pause A, Lee S, Worrell RA, Chen DY, Burgess WH, Linehan WM, Klausner RD.; ''The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.''; PubMed Europe PMC Scholia
  75. Groulx I, Lee S.; ''Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein.''; PubMed Europe PMC Scholia
  76. Putilina T, Jaworski C, Gentleman S, McDonald B, Kadiri M, Wong P.; ''Analysis of a human cDNA containing a tissue-specific alternatively spliced LIM domain.''; PubMed Europe PMC Scholia
  77. Kamura T, Maenaka K, Kotoshiba S, Matsumoto M, Kohda D, Conaway RC, Conaway JW, Nakayama KI.; ''VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.''; PubMed Europe PMC Scholia
  78. Yan J, Yan F, Li Z, Sinnott B, Cappell KM, Yu Y, Mo J, Duncan JA, Chen X, Cormier-Daire V, Whitehurst AW, Xiong Y.; ''The 3M complex maintains microtubule and genome integrity.''; PubMed Europe PMC Scholia
  79. Galgano A, Forrer M, Jaskiewicz L, Kanitz A, Zavolan M, Gerber AP.; ''Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.''; PubMed Europe PMC Scholia
  80. Andrews P, He YJ, Xiong Y.; ''Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.''; PubMed Europe PMC Scholia
  81. Maynard MA, Qi H, Chung J, Lee EH, Kondo Y, Hara S, Conaway RC, Conaway JW, Ohh M.; ''Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.''; PubMed Europe PMC Scholia
  82. Monda JK, Scott DC, Miller DJ, Lydeard J, King D, Harper JW, Bennett EJ, Schulman BA.; ''Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes.''; PubMed Europe PMC Scholia
  83. Kawakami T, Chiba T, Suzuki T, Iwai K, Yamanaka K, Minato N, Suzuki H, Shimbara N, Hidaka Y, Osaka F, Omata M, Tanaka K.; ''NEDD8 recruits E2-ubiquitin to SCF E3 ligase.''; PubMed Europe PMC Scholia
  84. Huang DT, Paydar A, Zhuang M, Waddell MB, Holton JM, Schulman BA.; ''Structural basis for recruitment of Ubc12 by an E2 binding domain in NEDD8's E1.''; PubMed Europe PMC Scholia
  85. Genau HM, Huber J, Baschieri F, Akutsu M, Dötsch V, Farhan H, Rogov V, Behrends C.; ''CUL3-KBTBD6/KBTBD7 ubiquitin ligase cooperates with GABARAP proteins to spatially restrict TIAM1-RAC1 signaling.''; PubMed Europe PMC Scholia
  86. Tan MK, Lim HJ, Bennett EJ, Shi Y, Harper JW.; ''Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover.''; PubMed Europe PMC Scholia
  87. Ohh M, Kim WY, Moslehi JJ, Chen Y, Chau V, Read MA, Kaelin WG.; ''An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells.''; PubMed Europe PMC Scholia
  88. Wu K, Yamoah K, Dolios G, Gan-Erdene T, Tan P, Chen A, Lee CG, Wei N, Wilkinson KD, Wang R, Pan ZQ.; ''DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1.''; PubMed Europe PMC Scholia
  89. Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW.; ''Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.''; PubMed Europe PMC Scholia
  90. Scott DC, Monda JK, Grace CR, Duda DM, Kriwacki RW, Kurz T, Schulman BA.; ''A dual E3 mechanism for Rub1 ligation to Cdc53.''; PubMed Europe PMC Scholia
  91. Bandau S, Knebel A, Gage ZO, Wood NT, Alexandru G.; ''UBXN7 docks on neddylated cullin complexes using its UIM motif and causes HIF1α accumulation.''; PubMed Europe PMC Scholia
  92. Wu K, Chen A, Pan ZQ.; ''Conjugation of Nedd8 to CUL1 enhances the ability of the ROC1-CUL1 complex to promote ubiquitin polymerization.''; PubMed Europe PMC Scholia
  93. Kelsall IR, Duda DM, Olszewski JL, Hofmann K, Knebel A, Langevin F, Wood N, Wightman M, Schulman BA, Alpi AF.; ''TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes.''; PubMed Europe PMC Scholia
  94. Voges D, Zwickl P, Baumeister W.; ''The 26S proteasome: a molecular machine designed for controlled proteolysis.''; PubMed Europe PMC Scholia
  95. Huang G, Stock C, Bommeljé CC, Weeda VB, Shah K, Bains S, Buss E, Shaha M, Rechler W, Ramanathan SY, Singh B.; ''SCCRO3 (DCUN1D3) antagonizes the neddylation and oncogenic activity of SCCRO (DCUN1D1).''; PubMed Europe PMC Scholia
  96. Keuss MJ, Thomas Y, Mcarthur R, Wood NT, Knebel A, Kurz T.; ''Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.''; PubMed Europe PMC Scholia
  97. Tanaka T, Nakatani T, Kamitani T.; ''Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.''; PubMed Europe PMC Scholia
  98. Lee S, Neumann M, Stearman R, Stauber R, Pause A, Pavlakis GN, Klausner RD.; ''Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.''; PubMed Europe PMC Scholia
  99. Pierce NW, Lee JE, Liu X, Sweredoski MJ, Graham RL, Larimore EA, Rome M, Zheng N, Clurman BE, Hess S, Shan SO, Deshaies RJ.; ''Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins.''; PubMed Europe PMC Scholia
  100. Cope GA, Deshaies RJ.; ''Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels.''; PubMed Europe PMC Scholia
  101. Singh RK, Iyappan S, Scheffner M.; ''Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.''; PubMed Europe PMC Scholia
  102. Matsuzawa K, Izawa S, Ohkura T, Ohkura H, Ishiguro K, Yoshida A, Takiyama Y, Haneda M, Shigemasa C, Yamamoto K, Taniguchi S.; ''Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms.''; PubMed Europe PMC Scholia
  103. Berra E, Roux D, Richard DE, Pouysségur J.; ''Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm.''; PubMed Europe PMC Scholia
  104. Arai T, Kasper JS, Skaar JR, Ali SH, Takahashi C, DeCaprio JA.; ''Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis.''; PubMed Europe PMC Scholia
  105. Liu G, Xirodimas DP.; ''NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways.''; PubMed Europe PMC Scholia
  106. Heir P, Sufan RI, Greer SN, Poon BP, Lee JE, Ohh M.; ''DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.''; PubMed Europe PMC Scholia
  107. Costoya JA, Hobbs RM, Pandolfi PP.; ''Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation.''; PubMed Europe PMC Scholia
  108. Zheng J, Yang X, Harrell JM, Ryzhikov S, Shim EH, Lykke-Andersen K, Wei N, Sun H, Kobayashi R, Zhang H.; ''CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex.''; PubMed Europe PMC Scholia
  109. Burstein E, Hoberg JE, Wilkinson AS, Rumble JM, Csomos RA, Komarck CM, Maine GN, Wilkinson JC, Mayo MW, Duckett CS.; ''COMMD proteins, a novel family of structural and functional homologs of MURR1.''; PubMed Europe PMC Scholia
  110. Lührig S, Kolb S, Mellies N, Nolte J.; ''The novel BTB-kelch protein, KBTBD8, is located in the Golgi apparatus and translocates to the spindle apparatus during mitosis.''; PubMed Europe PMC Scholia
  111. Fang L, Wang X, Yamoah K, Chen PL, Pan ZQ, Huang L.; ''Characterization of the human COP9 signalosome complex using affinity purification and mass spectrometry.''; PubMed Europe PMC Scholia
  112. Kito K, Yeh ET, Kamitani T.; ''NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression.''; PubMed Europe PMC Scholia
  113. Zemla A, Thomas Y, Kedziora S, Knebel A, Wood NT, Rabut G, Kurz T.; ''CSN- and CAND1-dependent remodelling of the budding yeast SCF complex.''; PubMed Europe PMC Scholia
  114. Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET.; ''CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.''; PubMed Europe PMC Scholia
  115. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ.; ''Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.''; PubMed Europe PMC Scholia
  116. Shiyanov P, Nag A, Raychaudhuri P.; ''Cullin 4A associates with the UV-damaged DNA-binding protein DDB.''; PubMed Europe PMC Scholia
  117. Chan Y, Yoon J, Wu JT, Kim HJ, Pan KT, Yim J, Chien CT.; ''DEN1 deneddylates non-cullin proteins in vivo.''; PubMed Europe PMC Scholia
  118. Ohh M, Park CW, Ivan M, Hoffman MA, Kim TY, Huang LE, Pavletich N, Chau V, Kaelin WG.; ''Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.''; PubMed Europe PMC Scholia
  119. Phillips-Krawczak CA, Singla A, Starokadomskyy P, Deng Z, Osborne DG, Li H, Dick CJ, Gomez TS, Koenecke M, Zhang JS, Dai H, Sifuentes-Dominguez LF, Geng LN, Kaufmann SH, Hein MY, Wallis M, McGaughran J, Gecz J, Sluis Bv, Billadeau DD, Burstein E.; ''COMMD1 is linked to the WASH complex and regulates endosomal trafficking of the copper transporter ATP7A.''; PubMed Europe PMC Scholia
  120. Yu F, White SB, Zhao Q, Lee FS.; ''Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein.''; PubMed Europe PMC Scholia
  121. Lydeard JR, Schulman BA, Harper JW.; ''Building and remodelling Cullin-RING E3 ubiquitin ligases.''; PubMed Europe PMC Scholia
  122. Walden H, Podgorski MS, Huang DT, Miller DW, Howard RJ, Minor DL, Holton JM, Schulman BA.; ''The structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis for selective ubiquitin-like protein activation by an E1.''; PubMed Europe PMC Scholia
  123. Wada H, Kito K, Caskey LS, Yeh ET, Kamitani T.; ''Cleavage of the C-terminus of NEDD8 by UCH-L3.''; PubMed Europe PMC Scholia
  124. Li ZH, Zhang XH, Li GY.; ''[Study on the fusion expression of FBXO30: a novel member of F-box protein family].''; PubMed Europe PMC Scholia
  125. Wei N, Serino G, Deng XW.; ''The COP9 signalosome: more than a protease.''; PubMed Europe PMC Scholia
  126. Oved S, Mosesson Y, Zwang Y, Santonico E, Shtiegman K, Marmor MD, Kochupurakkal BS, Katz M, Lavi S, Cesareni G, Yarden Y.; ''Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases.''; PubMed Europe PMC Scholia
  127. Yu F, White SB, Zhao Q, Lee FS.; ''HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.''; PubMed Europe PMC Scholia
  128. Tanji K, Tanaka T, Kamitani T.; ''Interaction of NUB1 with the proteasome subunit S5a.''; PubMed Europe PMC Scholia
  129. Tanimoto K, Makino Y, Pereira T, Poellinger L.; ''Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein.''; PubMed Europe PMC Scholia
  130. Enchev RI, Schulman BA, Peter M.; ''Protein neddylation: beyond cullin-RING ligases.''; PubMed Europe PMC Scholia
  131. Duda DM, Olszewski JL, Tron AE, Hammel M, Lambert LJ, Waddell MB, Mittag T, DeCaprio JA, Schulman BA.; ''Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface.''; PubMed Europe PMC Scholia
  132. Petroski MD, Deshaies RJ.; ''Function and regulation of cullin-RING ubiquitin ligases.''; PubMed Europe PMC Scholia
  133. Skaar JR, Florens L, Tsutsumi T, Arai T, Tron A, Swanson SK, Washburn MP, DeCaprio JA.; ''PARC and CUL7 form atypical cullin RING ligase complexes.''; PubMed Europe PMC Scholia
  134. Sufan RI, Ohh M.; ''Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex.''; PubMed Europe PMC Scholia
  135. Jeram SM, Srikumar T, Zhang XD, Anne Eisenhauer H, Rogers R, Pedrioli PG, Matunis M, Raught B.; ''An improved SUMmOn-based methodology for the identification of ubiquitin and ubiquitin-like protein conjugation sites identifies novel ubiquitin-like protein chain linkages.''; PubMed Europe PMC Scholia
  136. Scott DC, Sviderskiy VO, Monda JK, Lydeard JR, Cho SE, Harper JW, Schulman BA.; ''Structure of a RING E3 trapped in action reveals ligation mechanism for the ubiquitin-like protein NEDD8.''; PubMed Europe PMC Scholia
  137. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET.; ''Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1.''; PubMed Europe PMC Scholia
  138. Hu Q, Guo C, Li Y, Aronow BJ, Zhang J.; ''LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration.''; PubMed Europe PMC Scholia
  139. Mao X, Gluck N, Chen B, Starokadomskyy P, Li H, Maine GN, Burstein E.; ''COMMD1 (copper metabolism MURR1 domain-containing protein 1) regulates Cullin RING ligases by preventing CAND1 (Cullin-associated Nedd8-dissociated protein 1) binding.''; PubMed Europe PMC Scholia
  140. Okumura F, Joo-Okumura A, Nakatsukasa K, Kamura T.; ''The role of cullin 5-containing ubiquitin ligases.''; PubMed Europe PMC Scholia
  141. Xie P, Zhang M, He S, Lu K, Chen Y, Xing G, Lu Y, Liu P, Li Y, Wang S, Chai N, Wu J, Deng H, Wang HR, Cao Y, Zhao F, Cui Y, Wang J, He F, Zhang L.; ''The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis.''; PubMed Europe PMC Scholia
  142. Starokadomskyy P, Gluck N, Li H, Chen B, Wallis M, Maine GN, Mao X, Zaidi IW, Hein MY, McDonald FJ, Lenzner S, Zecha A, Ropers HH, Kuss AW, McGaughran J, Gecz J, Burstein E.; ''CCDC22 deficiency in humans blunts activation of proinflammatory NF-κB signaling.''; PubMed Europe PMC Scholia
  143. den Besten W, Verma R, Kleiger G, Oania RS, Deshaies RJ.; ''NEDD8 links cullin-RING ubiquitin ligase function to the p97 pathway.''; PubMed Europe PMC Scholia
  144. Li QZ, Wang CY, Shi JD, Ruan QG, Eckenrode S, Davoodi-Semiromi A, Kukar T, Gu Y, Lian W, Wu D, She JX.; ''Molecular cloning and characterization of the mouse and human TUSP gene, a novel member of the tubby superfamily.''; PubMed Europe PMC Scholia
  145. Katayama K, Noguchi K, Sugimoto Y.; ''FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitin--proteasome pathway in cancer cells.''; PubMed Europe PMC Scholia
  146. Lipkowitz S, Weissman AM.; ''RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.''; PubMed Europe PMC Scholia
  147. Zhang T, Dong K, Liang W, Xu D, Xia H, Geng J, Najafov A, Liu M, Li Y, Han X, Xiao J, Jin Z, Peng T, Gao Y, Cai Y, Qi C, Zhang Q, Sun A, Lipinski M, Zhu H, Xiong Y, Pandolfi PP, Li H, Yu Q, Yuan J.; ''G-protein-coupled receptors regulate autophagy by ZBTB16-mediated ubiquitination and proteasomal degradation of Atg14L.''; PubMed Europe PMC Scholia
  148. Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, Hipp MS, Groettrup M.; ''The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114664view16:13, 25 January 2021ReactomeTeamReactome version 75
113112view11:17, 2 November 2020ReactomeTeamReactome version 74
112346view15:27, 9 October 2020ReactomeTeamReactome version 73
101246view11:14, 1 November 2018ReactomeTeamreactome version 66
100785view20:41, 31 October 2018ReactomeTeamreactome version 65
100327view19:18, 31 October 2018ReactomeTeamreactome version 64
99873view16:01, 31 October 2018ReactomeTeamreactome version 63
99430view14:36, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93621view11:29, 9 August 2017ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
26S proteasomeComplexR-HSA-68819 (Reactome)
2xHP-EPAS1 ProteinQ99814 (Uniprot-TrEMBL)
2xHP-HIF1A ProteinQ16665 (Uniprot-TrEMBL)
AMPMetaboliteCHEBI:16027 (ChEBI)
ANKRD9 ProteinQ96BM1 (Uniprot-TrEMBL)
ASB1 ProteinQ9Y576 (Uniprot-TrEMBL)
ASB10 ProteinQ8WXI3 (Uniprot-TrEMBL)
ASB11 ProteinQ8WXH4 (Uniprot-TrEMBL)
ASB12 ProteinQ8WXK4 (Uniprot-TrEMBL)
ASB13 ProteinQ8WXK3 (Uniprot-TrEMBL)
ASB14 ProteinA6NK59 (Uniprot-TrEMBL)
ASB15 ProteinQ8WXK1 (Uniprot-TrEMBL)
ASB16 ProteinQ96NS5 (Uniprot-TrEMBL)
ASB17 ProteinQ8WXJ9 (Uniprot-TrEMBL)
ASB18 ProteinQ6ZVZ8 (Uniprot-TrEMBL)
ASB2 ProteinQ96Q27 (Uniprot-TrEMBL)
ASB3 ProteinQ9Y575 (Uniprot-TrEMBL)
ASB4 ProteinQ9Y574 (Uniprot-TrEMBL)
ASB5 ProteinQ8WWX0 (Uniprot-TrEMBL)
ASB6 ProteinQ9NWX5 (Uniprot-TrEMBL)
ASB7 ProteinQ9H672 (Uniprot-TrEMBL)
ASB8 ProteinQ9H765 (Uniprot-TrEMBL)
ASB9 ProteinQ96DX5 (Uniprot-TrEMBL)
ATPMetaboliteCHEBI:15422 (ChEBI)
AcM-UBE2F ProteinQ969M7 (Uniprot-TrEMBL)
AcM-UBE2F:NEDD8-UBA3:NAE1:NEDD8ComplexR-HSA-8951762 (Reactome)
AcM-UBE2FProteinQ969M7 (Uniprot-TrEMBL)
AcM-UBE2M ProteinP61081 (Uniprot-TrEMBL)
AcM-UBE2M:NEDD8-UBA3:NAE1:NEDD8ComplexR-HSA-8951749 (Reactome)
AcM-UBE2MProteinP61081 (Uniprot-TrEMBL)
BIRC5ProteinO15392 (Uniprot-TrEMBL)
BTBD1 ProteinQ9H0C5 (Uniprot-TrEMBL)
BTBD6 ProteinQ96KE9 (Uniprot-TrEMBL)
BTRC ProteinQ9Y297 (Uniprot-TrEMBL)
C111-AcM-UBE2M-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
C116-AcM-UBE2F-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
C237-UBA3-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
CAND1 ProteinQ86VP6 (Uniprot-TrEMBL)
CAND1ProteinQ86VP6 (Uniprot-TrEMBL)
CCDC22 ProteinO60826 (Uniprot-TrEMBL)
CCDC8 ProteinQ9H0W5 (Uniprot-TrEMBL)
CCNF ProteinP41002 (Uniprot-TrEMBL)
CISH ProteinQ9NSE2 (Uniprot-TrEMBL)
COMMD1 ProteinQ8N668 (Uniprot-TrEMBL)
COMMD10 ProteinQ9Y6G5 (Uniprot-TrEMBL)
COMMD2 ProteinQ86X83 (Uniprot-TrEMBL)
COMMD3 ProteinQ9UBI1 (Uniprot-TrEMBL)
COMMD4 ProteinQ9H0A8 (Uniprot-TrEMBL)
COMMD5 ProteinQ9GZQ3 (Uniprot-TrEMBL)
COMMD6 ProteinQ7Z4G1 (Uniprot-TrEMBL)
COMMD7 ProteinQ86VX2 (Uniprot-TrEMBL)
COMMD8 ProteinQ9NX08 (Uniprot-TrEMBL)
COMMD9 ProteinQ9P000 (Uniprot-TrEMBL)
COMMDs:CCDC22ComplexR-HSA-8955646 (Reactome)
COMMDs:CCDC22ComplexR-HSA-8955650 (Reactome)
COP9 signalosomeComplexR-HSA-5697024 (Reactome)
COP9ComplexR-HSA-416968 (Reactome)
COPS2 ProteinP61201 (Uniprot-TrEMBL)
COPS3 ProteinQ9UNS2 (Uniprot-TrEMBL)
COPS4 ProteinQ9BT78 (Uniprot-TrEMBL)
COPS5 ProteinQ92905 (Uniprot-TrEMBL)
COPS6 ProteinQ7L5N1 (Uniprot-TrEMBL)
COPS7A ProteinQ9UBW8 (Uniprot-TrEMBL)
COPS7B ProteinQ9H9Q2 (Uniprot-TrEMBL)
COPS8 ProteinQ99627 (Uniprot-TrEMBL)
CRL

E3 ubiquitin ligase

complex:COMMDs:CCDC22:DCUN1Ds
ComplexR-HSA-8956019 (Reactome)
CRL

E3 ubiquitin

ligase:COMMDs:CCDC22
ComplexR-HSA-8955229 (Reactome)
CRL E3 ubiquitin ligase:CAND1ComplexR-HSA-8955224 (Reactome)
CRL E3 ubiquitin ligasesComplexR-HSA-8955222 (Reactome)
CRL1

E3 ubiquitin ligase

complex:MyrG-DCUN1D3
ComplexR-HSA-8956203 (Reactome)
CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22
ComplexR-HSA-8955230 (Reactome)
CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1D1,2,4,5
ComplexR-HSA-8955960 (Reactome)
CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22
ComplexR-HSA-8955268 (Reactome)
CRL4 E3 ubiquitin ligase:CAND1ComplexR-HSA-8955244 (Reactome)
CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22
ComplexR-HSA-8955216 (Reactome)
CUL1 ProteinQ13616 (Uniprot-TrEMBL)
CUL2 ProteinQ13617 (Uniprot-TrEMBL)
CUL3 ProteinQ13618 (Uniprot-TrEMBL)
CUL4A ProteinQ13619 (Uniprot-TrEMBL)
CUL4B ProteinQ13620 (Uniprot-TrEMBL)
CUL5 ProteinQ93034 (Uniprot-TrEMBL)
CUL7 ProteinQ14999 (Uniprot-TrEMBL)
CUL7:CCDC8:OBSL1ComplexR-HSA-8955945 (Reactome)
CUL9 ProteinQ8IWT3 (Uniprot-TrEMBL)
CUL9:RBX1ComplexR-HSA-8855013 (Reactome)
DCAF10 ProteinQ5QP82 (Uniprot-TrEMBL)
DCAF11 ProteinQ8TEB1 (Uniprot-TrEMBL)
DCAF13 ProteinQ9NV06 (Uniprot-TrEMBL)
DCAF16 ProteinQ9NXF7 (Uniprot-TrEMBL)
DCAF17 ProteinQ5H9S7 (Uniprot-TrEMBL)
DCAF4 ProteinQ8WV16 (Uniprot-TrEMBL)
DCAF5 ProteinQ96JK2 (Uniprot-TrEMBL)
DCAF6 ProteinQ58WW2 (Uniprot-TrEMBL)
DCAF7 ProteinP61962 (Uniprot-TrEMBL)
DCAF8 ProteinQ5TAQ9 (Uniprot-TrEMBL)
DCUN1D1 ProteinQ96GG9 (Uniprot-TrEMBL)
DCUN1D1,2,4,5ComplexR-HSA-8952551 (Reactome)
DCUN1D2 ProteinQ6PH85 (Uniprot-TrEMBL)
DCUN1D3 ProteinQ8IWE4 (Uniprot-TrEMBL)
DCUN1D3 mRNA ProteinENST00000324344 (Ensembl)
DCUN1D3 mRNARnaENST00000324344 (Ensembl)
DCUN1D4 ProteinQ92564 (Uniprot-TrEMBL)
DCUN1D5 ProteinQ9BTE7 (Uniprot-TrEMBL)
DCUN1DsComplexR-HSA-8952553 (Reactome)
DDA1 ProteinQ9BW61 (Uniprot-TrEMBL)
DDB1 ProteinQ16531 (Uniprot-TrEMBL)
DDB2 ProteinQ92466 (Uniprot-TrEMBL)
DTL ProteinQ9NZJ0 (Uniprot-TrEMBL)
ELOC ProteinQ15369 (Uniprot-TrEMBL)
ERCC8 ProteinQ13216 (Uniprot-TrEMBL)
FBXL12 ProteinQ9NXK8 (Uniprot-TrEMBL)
FBXL13 ProteinQ8NEE6 (Uniprot-TrEMBL)
FBXL14 ProteinQ8N1E6 (Uniprot-TrEMBL)
FBXL15 ProteinQ9H469 (Uniprot-TrEMBL)
FBXL16 ProteinQ8N461 (Uniprot-TrEMBL)
FBXL18 ProteinQ96ME1 (Uniprot-TrEMBL)
FBXL19 ProteinQ6PCT2 (Uniprot-TrEMBL)
FBXL20 ProteinQ96IG2 (Uniprot-TrEMBL)
FBXL21 ProteinQ9UKT6 (Uniprot-TrEMBL)
FBXL22 ProteinQ6P050 (Uniprot-TrEMBL)
FBXL3 ProteinQ9UKT7 (Uniprot-TrEMBL)
FBXL4 ProteinQ9UKA2 (Uniprot-TrEMBL)
FBXL5 ProteinQ9UKA1 (Uniprot-TrEMBL)
FBXL7 ProteinQ9UJT9 (Uniprot-TrEMBL)
FBXL8 ProteinQ96CD0 (Uniprot-TrEMBL)
FBXO10 ProteinQ9UK96 (Uniprot-TrEMBL)
FBXO11 ProteinQ86XK2 (Uniprot-TrEMBL)
FBXO15 ProteinQ8NCQ5 (Uniprot-TrEMBL)
FBXO17 ProteinQ96EF6 (Uniprot-TrEMBL)
FBXO2 ProteinQ9UK22 (Uniprot-TrEMBL)
FBXO21 ProteinO94952 (Uniprot-TrEMBL)
FBXO22 ProteinQ8NEZ5 (Uniprot-TrEMBL)
FBXO27 ProteinQ8NI29 (Uniprot-TrEMBL)
FBXO30 ProteinQ8TB52 (Uniprot-TrEMBL)
FBXO31 ProteinQ5XUX0 (Uniprot-TrEMBL)
FBXO32 ProteinQ969P5 (Uniprot-TrEMBL)
FBXO4 ProteinQ9UKT5 (Uniprot-TrEMBL)
FBXO40 ProteinQ9UH90 (Uniprot-TrEMBL)
FBXO41 ProteinQ8TF61 (Uniprot-TrEMBL)
FBXO44 ProteinQ9H4M3 (Uniprot-TrEMBL)
FBXO6 ProteinQ9NRD1 (Uniprot-TrEMBL)
FBXO7 ProteinQ9Y3I1 (Uniprot-TrEMBL)
FBXO9 ProteinQ9UK97 (Uniprot-TrEMBL)
FBXW10 ProteinQ5XX13 (Uniprot-TrEMBL)
FBXW11 ProteinQ9UKB1 (Uniprot-TrEMBL)
FBXW12 ProteinQ6X9E4 (Uniprot-TrEMBL)
FBXW2 ProteinQ9UKT8 (Uniprot-TrEMBL)
FBXW4 ProteinP57775 (Uniprot-TrEMBL)
FBXW5 ProteinQ969U6 (Uniprot-TrEMBL)
FBXW7 ProteinQ969H0 (Uniprot-TrEMBL)
FBXW8 ProteinQ8N3Y1 (Uniprot-TrEMBL)
FBXW9 ProteinQ5XUX1 (Uniprot-TrEMBL)
FEM1A ProteinQ9BSK4 (Uniprot-TrEMBL)
FEM1B ProteinQ9UK73 (Uniprot-TrEMBL)
FEM1C ProteinQ96JP0 (Uniprot-TrEMBL)
G76-NEDD8-C111-AcM-UBE2M ProteinP61081 (Uniprot-TrEMBL)
G76-NEDD8-C116-AcM-UBE2F ProteinQ969M7 (Uniprot-TrEMBL)
G76-NEDD8-C237-UBA3 ProteinQ8TBC4 (Uniprot-TrEMBL)
G76-NEDD8-K1881-CUL9 ProteinQ8IWT3 (Uniprot-TrEMBL)
G76-NEDD8-K689-CUL2 ProteinQ13617 (Uniprot-TrEMBL)
G76-NEDD8-K705-CUL4A ProteinQ13619 (Uniprot-TrEMBL)
G76-NEDD8-K712-CUL3 ProteinQ13618 (Uniprot-TrEMBL)
G76-NEDD8-K720-CUL1 ProteinQ13616 (Uniprot-TrEMBL)
G76-NEDD8-K724-CUL5 ProteinQ93034 (Uniprot-TrEMBL)
G76-NEDD8-K859-CUL4B ProteinQ13620 (Uniprot-TrEMBL)
GAN ProteinQ9H2C0 (Uniprot-TrEMBL)
GPS1 ProteinQ13098 (Uniprot-TrEMBL)
H2OMetaboliteCHEBI:15377 (ChEBI)
HP-HIF3A ProteinQ9Y2N7 (Uniprot-TrEMBL)
K1881-CUL9-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
K689-CUL2-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
K705-CUL4A-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
K712-CUL3-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
K720-CUL1-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
K724-CUL5-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
K859-CUL4B-G76-NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
KBTBD13 ProteinC9JR72 (Uniprot-TrEMBL)
KBTBD6 ProteinQ86V97 (Uniprot-TrEMBL)
KBTBD7 ProteinQ8WVZ9 (Uniprot-TrEMBL)
KBTBD8 ProteinQ8NFY9 (Uniprot-TrEMBL)
KCTD6 ProteinQ8NC69 (Uniprot-TrEMBL)
KCTD7 ProteinQ96MP8 (Uniprot-TrEMBL)
KEAP1 ProteinQ14145 (Uniprot-TrEMBL)
KLHL11 ProteinQ9NVR0 (Uniprot-TrEMBL)
KLHL13 ProteinQ9P2N7 (Uniprot-TrEMBL)
KLHL2 ProteinO95198 (Uniprot-TrEMBL)
KLHL20 ProteinQ9Y2M5 (Uniprot-TrEMBL)
KLHL21 ProteinQ9UJP4 (Uniprot-TrEMBL)
KLHL22 ProteinQ53GT1 (Uniprot-TrEMBL)
KLHL25 ProteinQ9H0H3 (Uniprot-TrEMBL)
KLHL3 ProteinQ9UH77 (Uniprot-TrEMBL)
KLHL41 ProteinO60662 (Uniprot-TrEMBL)
KLHL42 ProteinQ9P2K6 (Uniprot-TrEMBL)
KLHL5 ProteinQ96PQ7 (Uniprot-TrEMBL)
KLHL9 ProteinQ9P2J3 (Uniprot-TrEMBL)
LMO7 ProteinQ8WWI1 (Uniprot-TrEMBL)
LRR1 ProteinQ96L50 (Uniprot-TrEMBL)
LRRC41 ProteinQ15345 (Uniprot-TrEMBL)
MyrG-DCUN1D3 ProteinQ8IWE4 (Uniprot-TrEMBL)
MyrG-DCUN1D3ProteinQ8IWE4 (Uniprot-TrEMBL)
NAE1 ProteinQ13564 (Uniprot-TrEMBL)
NEDD8

CRL E3 ubiquitin

ligases:COMMDs:CCDC22:DCUN1Ds
ComplexR-HSA-8956021 (Reactome)
NEDD8 ProteinQ15843 (Uniprot-TrEMBL)
NEDD8(1-88) ProteinQ15843 (Uniprot-TrEMBL)
NEDD8(77-88)ProteinQ15843 (Uniprot-TrEMBL)
NEDD8,UBD:NUB1:26S proteasomeComplexR-HSA-8956137 (Reactome)
NEDD8,UBDComplexR-HSA-8956136 (Reactome)
NEDD8-AcM-UBE2F:CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ComplexR-HSA-8952026 (Reactome)
NEDD8-AcM-UBE2FComplexR-HSA-8951756 (Reactome)
NEDD8-AcM-UBE2M:CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ComplexR-HSA-8952572 (Reactome)
NEDD8-AcM-UBE2M:CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUND1,2,4,5
ComplexR-HSA-8952580 (Reactome)
NEDD8-AcM-UBE2M:CUL9:RBX1ComplexR-HSA-8955949 (Reactome)
NEDD8-AcM-UBE2MComplexR-HSA-4419896 (Reactome)
NEDD8-AcM-UBE2MComplexR-HSA-8952569 (Reactome)
NEDD8-CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ComplexR-HSA-8952593 (Reactome)
NEDD8-CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1D1,2,4,5
ComplexR-HSA-8952585 (Reactome)
NEDD8-CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ComplexR-HSA-8952024 (Reactome)
NEDD8-CUL9:RBX1:CUL7:CCDC8:OBSL1ComplexR-HSA-8955943 (Reactome)
NEDD8-CUL9:RBX1ComplexR-HSA-8955941 (Reactome)
NEDD8-UBA3:NAE1:NEDD8ComplexR-HSA-8951658 (Reactome)
NEDD8-UBA3:NAE1ComplexR-HSA-8951646 (Reactome)
NEDD8ProteinQ15843 (Uniprot-TrEMBL)
NEURL2 ProteinQ9BR09 (Uniprot-TrEMBL)
NUB1-1 ProteinQ9Y5A7-1 (Uniprot-TrEMBL)
NUB1-2 ProteinQ9Y5A7-2 (Uniprot-TrEMBL)
NUB1ComplexR-HSA-8956132 (Reactome)
OBSL1 ProteinO75147 (Uniprot-TrEMBL)
PPiMetaboliteCHEBI:29888 (ChEBI)
PSMA1 ProteinP25786 (Uniprot-TrEMBL)
PSMA2 ProteinP25787 (Uniprot-TrEMBL)
PSMA3 ProteinP25788 (Uniprot-TrEMBL)
PSMA4 ProteinP25789 (Uniprot-TrEMBL)
PSMA5 ProteinP28066 (Uniprot-TrEMBL)
PSMA6 ProteinP60900 (Uniprot-TrEMBL)
PSMA7 ProteinO14818 (Uniprot-TrEMBL)
PSMA8 ProteinQ8TAA3 (Uniprot-TrEMBL)
PSMB1 ProteinP20618 (Uniprot-TrEMBL)
PSMB10 ProteinP40306 (Uniprot-TrEMBL)
PSMB11 ProteinA5LHX3 (Uniprot-TrEMBL)
PSMB2 ProteinP49721 (Uniprot-TrEMBL)
PSMB3 ProteinP49720 (Uniprot-TrEMBL)
PSMB4 ProteinP28070 (Uniprot-TrEMBL)
PSMB5 ProteinP28074 (Uniprot-TrEMBL)
PSMB6 ProteinP28072 (Uniprot-TrEMBL)
PSMB7 ProteinQ99436 (Uniprot-TrEMBL)
PSMB8 ProteinP28062 (Uniprot-TrEMBL)
PSMB9 ProteinP28065 (Uniprot-TrEMBL)
PSMC1 ProteinP62191 (Uniprot-TrEMBL)
PSMC2 ProteinP35998 (Uniprot-TrEMBL)
PSMC3 ProteinP17980 (Uniprot-TrEMBL)
PSMC4 ProteinP43686 (Uniprot-TrEMBL)
PSMC5 ProteinP62195 (Uniprot-TrEMBL)
PSMC6 ProteinP62333 (Uniprot-TrEMBL)
PSMD1 ProteinQ99460 (Uniprot-TrEMBL)
PSMD10 ProteinO75832 (Uniprot-TrEMBL)
PSMD11 ProteinO00231 (Uniprot-TrEMBL)
PSMD12 ProteinO00232 (Uniprot-TrEMBL)
PSMD13 ProteinQ9UNM6 (Uniprot-TrEMBL)
PSMD14 ProteinO00487 (Uniprot-TrEMBL)
PSMD2 ProteinQ13200 (Uniprot-TrEMBL)
PSMD3 ProteinO43242 (Uniprot-TrEMBL)
PSMD4 ProteinP55036 (Uniprot-TrEMBL)
PSMD5 ProteinQ16401 (Uniprot-TrEMBL)
PSMD6 ProteinQ15008 (Uniprot-TrEMBL)
PSMD7 ProteinP51665 (Uniprot-TrEMBL)
PSMD8 ProteinP48556 (Uniprot-TrEMBL)
PSMD9 ProteinO00233 (Uniprot-TrEMBL)
PSME1 ProteinQ06323 (Uniprot-TrEMBL)
PSME2 ProteinQ9UL46 (Uniprot-TrEMBL)
PSME3 ProteinP61289 (Uniprot-TrEMBL)
PSME4 ProteinQ14997 (Uniprot-TrEMBL)
PSMF1 ProteinQ92530 (Uniprot-TrEMBL)
PUM2 ProteinQ8TB72 (Uniprot-TrEMBL)
PUM2:DCUN1D3 mRNAComplexR-HSA-8956232 (Reactome)
RBBP5 ProteinQ15291 (Uniprot-TrEMBL)
RBBP7 ProteinQ16576 (Uniprot-TrEMBL)
RBX1 ProteinP62877 (Uniprot-TrEMBL)
RBX1:CUL4:DDB1:DCAFsComplexR-HSA-976149 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:UBXN7ComplexR-HSA-8956077 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:hydroxyPro-HIF-alphaComplexR-HSA-8956082 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5ComplexR-HSA-8956074 (Reactome)
RFWD2 ProteinQ8NHY2 (Uniprot-TrEMBL)
RNF7 (RBX2) ProteinQ9UBF6 (Uniprot-TrEMBL)
RPS27A(1-76) ProteinP62979 (Uniprot-TrEMBL)
SENP8 ProteinQ96LD8 (Uniprot-TrEMBL)
SHFM1 ProteinP60896 (Uniprot-TrEMBL)
SKP1 ProteinP63208 (Uniprot-TrEMBL)
SKP2 ProteinQ13309 (Uniprot-TrEMBL)
SOCS2 ProteinO14508 (Uniprot-TrEMBL)
SOCS3 ProteinO14543 (Uniprot-TrEMBL)
SOCS5 ProteinO75159 (Uniprot-TrEMBL)
SOCS6 ProteinO14544 (Uniprot-TrEMBL)
SPSB1 ProteinQ96BD6 (Uniprot-TrEMBL)
SPSB2 ProteinQ99619 (Uniprot-TrEMBL)
SPSB3 ProteinQ6PJ21 (Uniprot-TrEMBL)
SPSB4 ProteinQ96A44 (Uniprot-TrEMBL)
TCEB2 ProteinQ15370 (Uniprot-TrEMBL)
TULP4 ProteinQ9NRJ4 (Uniprot-TrEMBL)
UBA3 ProteinQ8TBC4 (Uniprot-TrEMBL)
UBA3:NAE1ComplexR-HSA-8951642 (Reactome)
UBA52(1-76) ProteinP62987 (Uniprot-TrEMBL)
UBB(1-76) ProteinP0CG47 (Uniprot-TrEMBL)
UBB(153-228) ProteinP0CG47 (Uniprot-TrEMBL)
UBB(77-152) ProteinP0CG47 (Uniprot-TrEMBL)
UBC(1-76) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(153-228) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(229-304) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(305-380) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(381-456) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(457-532) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(533-608) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(609-684) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(77-152) ProteinP0CG48 (Uniprot-TrEMBL)
UBD ProteinO15205 (Uniprot-TrEMBL)
UBE2D1 ProteinP51668 (Uniprot-TrEMBL)
UBE2D1,2,3:UbiquitinComplexR-HSA-1234116 (Reactome)
UBE2D1,2,3ComplexR-HSA-1234120 (Reactome)
UBE2D2 ProteinP62837 (Uniprot-TrEMBL)
UBE2D3 ProteinP61077 (Uniprot-TrEMBL)
UBXN7 ProteinO94888 (Uniprot-TrEMBL)
UBXN7ProteinO94888 (Uniprot-TrEMBL)
UCHL3 ProteinP15374 (Uniprot-TrEMBL)
UCHL3,SENP8:NEDD8(1-88)ComplexR-HSA-6782635 (Reactome)
UCHL3,SENP8:NEDD8ComplexR-HSA-6782643 (Reactome)
UCHL3,SENP8ComplexR-HSA-5690783 (Reactome)
UbComplexR-HSA-113595 (Reactome)
VHL ProteinP40337 (Uniprot-TrEMBL)
WDR5 ProteinP61964 (Uniprot-TrEMBL)
WDTC1 ProteinQ8N5D0 (Uniprot-TrEMBL)
WSB1 ProteinQ9Y6I7 (Uniprot-TrEMBL)
WSB2 ProteinQ9NYS7 (Uniprot-TrEMBL)
ZBTB16 ProteinQ05516 (Uniprot-TrEMBL)
hydroxyPro-HIF-alphaComplexR-HSA-1234106 (Reactome)
ub-BIRC5ProteinO15392 (Uniprot-TrEMBL)
ub-hydroxyPro-HIF-alpha:VHL:EloB:EloC:NEDD8-CUL2:RBX1:COMMDs:CCDC22:DCUN1D1,2,4,5ComplexR-HSA-8956079 (Reactome)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
26S proteasomeArrowR-HSA-8956184 (Reactome)
26S proteasomeR-HSA-8956140 (Reactome)
AMPArrowR-HSA-8951648 (Reactome)
AMPArrowR-HSA-8951656 (Reactome)
ATPR-HSA-8951648 (Reactome)
ATPR-HSA-8951656 (Reactome)
AcM-UBE2F:NEDD8-UBA3:NAE1:NEDD8ArrowR-HSA-8951766 (Reactome)
AcM-UBE2F:NEDD8-UBA3:NAE1:NEDD8R-HSA-8951764 (Reactome)
AcM-UBE2F:NEDD8-UBA3:NAE1:NEDD8mim-catalysisR-HSA-8951764 (Reactome)
AcM-UBE2FArrowR-HSA-8952044 (Reactome)
AcM-UBE2FR-HSA-8951766 (Reactome)
AcM-UBE2M:NEDD8-UBA3:NAE1:NEDD8ArrowR-HSA-8951751 (Reactome)
AcM-UBE2M:NEDD8-UBA3:NAE1:NEDD8R-HSA-8951661 (Reactome)
AcM-UBE2M:NEDD8-UBA3:NAE1:NEDD8mim-catalysisR-HSA-8951661 (Reactome)
AcM-UBE2MArrowR-HSA-8952618 (Reactome)
AcM-UBE2MArrowR-HSA-8952638 (Reactome)
AcM-UBE2MArrowR-HSA-8956025 (Reactome)
AcM-UBE2MR-HSA-8951751 (Reactome)
BIRC5R-HSA-8956026 (Reactome)
CAND1ArrowR-HSA-8955285 (Reactome)
CAND1ArrowR-HSA-8955289 (Reactome)
CAND1R-HSA-8955241 (Reactome)
CAND1R-HSA-8955245 (Reactome)
COMMDs:CCDC22R-HSA-8955285 (Reactome)
COMMDs:CCDC22R-HSA-8955289 (Reactome)
COP9 signalosomemim-catalysisR-HSA-8956045 (Reactome)
COP9mim-catalysisR-HSA-8956040 (Reactome)
CRL

E3 ubiquitin ligase

complex:COMMDs:CCDC22:DCUN1Ds
ArrowR-HSA-8956040 (Reactome)
CRL

E3 ubiquitin

ligase:COMMDs:CCDC22
ArrowR-HSA-8955289 (Reactome)
CRL E3 ubiquitin ligase:CAND1ArrowR-HSA-8955241 (Reactome)
CRL E3 ubiquitin ligase:CAND1R-HSA-8955289 (Reactome)
CRL E3 ubiquitin ligasesR-HSA-8955241 (Reactome)
CRL1

E3 ubiquitin ligase

complex:MyrG-DCUN1D3
ArrowR-HSA-8956200 (Reactome)
CRL1

E3 ubiquitin ligase

complex:MyrG-DCUN1D3
TBarR-HSA-8952618 (Reactome)
CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22
R-HSA-8952620 (Reactome)
CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22
R-HSA-8956200 (Reactome)
CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1D1,2,4,5
ArrowR-HSA-8956045 (Reactome)
CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22
ArrowR-HSA-8955285 (Reactome)
CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22
R-HSA-8952639 (Reactome)
CRL4 E3 ubiquitin ligase:CAND1ArrowR-HSA-8955245 (Reactome)
CRL4 E3 ubiquitin ligase:CAND1R-HSA-8955285 (Reactome)
CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22
R-HSA-8952039 (Reactome)
CUL7:CCDC8:OBSL1R-HSA-8956050 (Reactome)
CUL9:RBX1R-HSA-8956031 (Reactome)
DCUN1D1,2,4,5R-HSA-8952639 (Reactome)
DCUN1D3 mRNAR-HSA-8956234 (Reactome)
DCUN1DsR-HSA-8952039 (Reactome)
DCUN1DsR-HSA-8952620 (Reactome)
H2OR-HSA-5690808 (Reactome)
MyrG-DCUN1D3ArrowR-HSA-8956234 (Reactome)
MyrG-DCUN1D3R-HSA-8956200 (Reactome)
NEDD8

CRL E3 ubiquitin

ligases:COMMDs:CCDC22:DCUN1Ds
R-HSA-8956040 (Reactome)
NEDD8(77-88)ArrowR-HSA-5690808 (Reactome)
NEDD8,UBD:NUB1:26S proteasomeArrowR-HSA-8956140 (Reactome)
NEDD8,UBD:NUB1:26S proteasomeR-HSA-8956184 (Reactome)
NEDD8,UBDR-HSA-8956140 (Reactome)
NEDD8-AcM-UBE2F:CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ArrowR-HSA-8952039 (Reactome)
NEDD8-AcM-UBE2F:CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
R-HSA-8952044 (Reactome)
NEDD8-AcM-UBE2F:CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
mim-catalysisR-HSA-8952044 (Reactome)
NEDD8-AcM-UBE2FArrowR-HSA-8951764 (Reactome)
NEDD8-AcM-UBE2FR-HSA-8952039 (Reactome)
NEDD8-AcM-UBE2M:CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ArrowR-HSA-8952620 (Reactome)
NEDD8-AcM-UBE2M:CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
R-HSA-8952618 (Reactome)
NEDD8-AcM-UBE2M:CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
mim-catalysisR-HSA-8952618 (Reactome)
NEDD8-AcM-UBE2M:CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUND1,2,4,5
ArrowR-HSA-8952639 (Reactome)
NEDD8-AcM-UBE2M:CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUND1,2,4,5
R-HSA-8952638 (Reactome)
NEDD8-AcM-UBE2M:CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUND1,2,4,5
mim-catalysisR-HSA-8952638 (Reactome)
NEDD8-AcM-UBE2M:CUL9:RBX1ArrowR-HSA-8956031 (Reactome)
NEDD8-AcM-UBE2M:CUL9:RBX1R-HSA-8956025 (Reactome)
NEDD8-AcM-UBE2M:CUL9:RBX1mim-catalysisR-HSA-8956025 (Reactome)
NEDD8-AcM-UBE2MArrowR-HSA-8951661 (Reactome)
NEDD8-AcM-UBE2MR-HSA-8952620 (Reactome)
NEDD8-AcM-UBE2MR-HSA-8952639 (Reactome)
NEDD8-AcM-UBE2MR-HSA-8956031 (Reactome)
NEDD8-CRL1

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ArrowR-HSA-8952618 (Reactome)
NEDD8-CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1D1,2,4,5
ArrowR-HSA-8952638 (Reactome)
NEDD8-CRL4

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1D1,2,4,5
R-HSA-8956045 (Reactome)
NEDD8-CRL5

E3 ubiquitin

ligase:COMMDs:CCDC22:DCUN1Ds
ArrowR-HSA-8952044 (Reactome)
NEDD8-CUL9:RBX1:CUL7:CCDC8:OBSL1ArrowR-HSA-8956050 (Reactome)
NEDD8-CUL9:RBX1:CUL7:CCDC8:OBSL1TBarR-HSA-8956026 (Reactome)
NEDD8-CUL9:RBX1ArrowR-HSA-8956025 (Reactome)
NEDD8-CUL9:RBX1R-HSA-8956050 (Reactome)
NEDD8-CUL9:RBX1mim-catalysisR-HSA-8956026 (Reactome)
NEDD8-UBA3:NAE1:NEDD8ArrowR-HSA-8951656 (Reactome)
NEDD8-UBA3:NAE1:NEDD8R-HSA-8951751 (Reactome)
NEDD8-UBA3:NAE1:NEDD8R-HSA-8951766 (Reactome)
NEDD8-UBA3:NAE1ArrowR-HSA-8951648 (Reactome)
NEDD8-UBA3:NAE1ArrowR-HSA-8951661 (Reactome)
NEDD8-UBA3:NAE1ArrowR-HSA-8951764 (Reactome)
NEDD8-UBA3:NAE1R-HSA-8951656 (Reactome)
NEDD8ArrowR-HSA-8951644 (Reactome)
NEDD8ArrowR-HSA-8956040 (Reactome)
NEDD8ArrowR-HSA-8956045 (Reactome)
NEDD8R-HSA-8951648 (Reactome)
NEDD8R-HSA-8951656 (Reactome)
NUB1ArrowR-HSA-8956184 (Reactome)
NUB1R-HSA-8956140 (Reactome)
PPiArrowR-HSA-8951648 (Reactome)
PPiArrowR-HSA-8951656 (Reactome)
PUM2:DCUN1D3 mRNATBarR-HSA-8956234 (Reactome)
R-HSA-5690808 (Reactome) UCHL3 and SENP8 (DEN1) remove the C-terminal extension of NEDD8 propeptides, exposing a C-terminal Gly residue. UCHL3 can also process ubiquitin (Wada et al. 1998). UCHL3 and SENP8 are probably functionally redundant in NEDD8 processing as deletion of either enzyme does not lead to neddylation defects (Chan et al. 2008, Kurihara et al. 2000).
R-HSA-8951644 (Reactome) After C-terminal processing by UCHL3 or SENP8, mature NEDD8 is released (Wada et al, 1998; Wu et al, 2003).
R-HSA-8951648 (Reactome) NEDD8 is attached via a thioester bond to the catalytic cysteine of its E1 as the first step in its transfer to substrates (Walden et al, 2003). The NEDD8 E1 is a heterodimer consisting of UBA3 and NAE1, and transfers NEDD8 to the E2 enzymes from a 'doubly loaded' state. In the first step, NEDD8 binds to the adenylation site on the NAE1 subunit in conjuction with ATP and Mg2+, generating a covalently modified NEDD8-adenylate conjugate. This conjugation activates the NEDD8 C-terminus for chemical attack by the thiol group of the catalytic cysteine of the UBA3 subunit. Catalysis is likely facilitated by a conformational change in the E1 enzyme. After catalysis, NEDD8 is covalently bound in the E1 catalytic site, leaving the adenylation site free to bind another NEDD8 molecule in the second step, prior to NEDD8 transfer to an E2 enzyme (Walden et al, 2003; Huang et al, 2004; Huang et al, 2005; Huang et al, 2007).
R-HSA-8951656 (Reactome) After covalent attachment of the first NEDD8 molecule to the catalytic cysteine, a second NEDD8 binds to the now-free adenylation site on the UBA3 subunit of UBA3:NAE1. This 'doubly-loaded' E1 enzyme is primed to transfer the covalently-bound NEDD8 to the downstream E2 enzyme (Huang et al, 2005; Huang et al, 2007; reviewed in Enchev et al, 2015). Note that although not depicted here, the second NEDD8 moiety is covalently adenylated at its C-terminal glycine residue at the end of this reaction.
R-HSA-8951661 (Reactome) UBA3:NAE1 transfers NEDD8 to the catalytic cysteine residue of UBE2M. Because two of the three E1-E2 interaction interfaces are created by conformational states present in the doubly-NEDDylated NAE1, transfer of NEDD8 to UBE2M is thought to weaken the interaction between UBA3:NAE1 and UBE2M, contributing to UBE2M release (Walden et al, 2003; Huang et al, 2004; Hunag et al, 2005; Huang et al, 2007).
R-HSA-8951751 (Reactome) When NAE1:UBA3 is doubly loaded with NEDD8 (one molecule covalently attached to the catalytic cysteine and the other bound in the adenylation site), the E1 enzyme is competent to interact with either of its E2 enzymes, UBE2F and UBE2M (also known as UBC12). Three binding interfaces contribute to the interaction of the E1 and E2 enzymes. When doubly neddylated, the "ubiquitin" folding domain of NAE1 reorients and, in conjunction with the adenylation domain, forms a cryptic E2-binding site. The adenylation domain also makes contact with the amino terminus of either E2 enzyme. UBE2M additionally interacts directly with the NEDD8 molecule covalently attached to the E1 catalytic cysteine (Huang et al, 2004; Huang et al, 2007; reviewed in Enchev et al, 2015). UBE2M is the E2 responsible for transfer of NEDD8 to RBX1-containing E3 ligase complexes, such as those formed with cullins 1, 2, 3 and 4. In contrast, UBE2F is the E2 for the CUL5:RBX2-containing E3 ligase (Huang et al, 2009).
R-HSA-8951764 (Reactome) UBA3:NAE1 transfers NEDD8 to the catalytic cysteine residue of UBE2F. Because two of the three E1-E2 interaction interfaces are created by conformational states present in the doubly-NEDDylated NAE1, transfer of NEDD8 to UBE2M is thought to weaken the interaction between UBA3:NAE1 and UBE2F, contributing to UBE2F release (Walden et al, 2003; Huang et al, 2004; Hunag et al, 2005; Huang et al, 2007).
R-HSA-8951766 (Reactome) When NAE1:UBA3 is doubly loaded with NEDD8 (one molecule covalently attached to the catalytic cysteine and the other bound in the adenylation site), the E1 enzyme is competent to interact with either of its E2 enzymes, UBE2F and UBE2M (also known as UBC12). Three binding interfaces contribute to the interaction of the E1 and E2 enzymes. When doubly neddylated, the ubiquitin fold domain of NAE1 reorients and, in conjunction with the adenylation domain, forms a cryptic E2-binding site. The adenylation domain also makes contact with the amino terminus of either E2 enzyme. UBE2M additionally interacts directly with the NEDD8 molecule covalently attached to the E1 catalytic cysteine (Huang et al, 2004; Huang et al, 2007; reviewed in Enchev et al, 2015).
UBE2F is the E2 responsible for the transfer of NEDD8 to the CUL5:RBX2 E3 ligase complex, while UBE2M is specific for RBX1-containing E3 ligase complexes formed with CUL1-4 (Huang et al, 2009; reviewed in Mahon et al, 2014).
R-HSA-8952039 (Reactome) UBE2F is specific for the CUL5:RBX2-containing E3 ligase complex (Huang et al, 2009; Monda et al, 2013). Interaction between UBE2F and the CUL5 E3 complex is facilitated by a DCUN1D (also known as DCNL) scaffold protein, of which there are 5 in human cells (Kim et al, 2008; Kurz et al, 2008; Meyer-Schaller et al, 2009; Monda et al, 2013; Keuss et al, 2016). DCUN1D proteins interact with higher affinity to the N-terminally acetylated forms of UBE2F and UBE2M (Scott et al, 2011; Monda et al, 2013). Although each of the 5 DCUN1D proteins appears to interact with most cullin subtypes, specificity may arise through differences in expression and localization, and DCUN1D3 may play a specialized role in sequestering CRL E3 ligase complexes at the cell membrane (Monda et al, 2013; Keuss et al, 2016; Meyer-Schaller et al, 2009; Huang et al, 2014; reviewed in Enchev et al, 2103). Although in this pathway, COMMD proteins and DCUN1D are shown acting sequentially in the activation of the CRL E3 ligase complex, the relationship between these protein families is not totally clear, as DCUN1D proteins have been identified in complexes that also contain the inhibitor CAND1 (Kim et al, 2008; Huang et al, 2014).
CUL5 RING complexes target a variety of cellular proteins for ubiquitination and degradation, including receptor and non-receptor tyrosine kinases, signaling molecules transcriptional regulators (reviewed in Okumura et al, 2016). CRL5 complexes are also hijacked by viruses such as HIV and HPV, among others. Interaction with viral proteins redirects the ubiquitin ligase complex, targeting host proteins such as immune factors and in this way promoting viral propagation (reveiwed in Mahon et al, 2014).
R-HSA-8952044 (Reactome) UBE2F transfers NEDD8 to lysine 724 of CUL5 in the E3 ligase complex (Duda et al, 2008). Neddylation increases the ubiquitination activity of the E3 complex towards its target, and prevents binding of the CUL5 complex with the CAND1 inhibitor (Hori et al, 1999; Duda et al, 2008; Kelsall et al, 2013). Targets of CUL5 RING complexes include a variety of cellular proteins including receptor and non-receptor tyrosine kinases, signaling molecules transcriptional regulators (reviewed in Okamura et al, 2016). CRL5 complexes are also hijacked by viruses such as HIV, HPV and adenovirus among others. Interaction with viral proteins redirects the ubiquitin ligase complex to target host proteins to promote conditions that favor viral propagation (Harada et al, 2002; Mehle et al, 2004; reviewed in Mahon et al, 2014).
R-HSA-8952618 (Reactome) UBE2M transfers NEDD8 to lysine 720 of CUL1 in the CRL E3 ubiquitin ligase complex (Hori et al, 1999; Duda et al, 2008). Neddylation increases the ubiquitination activity of the E3 complex towards its targets, and prevents binding of the CUL1 complex with the CAND1 inhibitor (Hori et al, 1999; Goldenberg et al, 2004; Duda et al, 2008; Kelsall et al, 2013; Scott et al, 2016). Targets of CUL1 RING complexes include a variety of cellular proteins including regulators of transcription and cell cycle progression, among others (reviewed in Lipkowitz and Weissman, 2011). CRL1 complexes are also hijacked by viruses, redirecting the ubiquitin ligase complex to target host proteins (reviewed in Mahon et al, 2014).
R-HSA-8952620 (Reactome) UBE2M is the E2 for CRL complexes containing cullin 1, 2, 3 and 4 (Huang et al, 2009; Monda et al, 2013). Interaction between UBE2M and the CUL1 E3 complex is facilitated by a DCUN1D (also known as DCNL) scaffold protein, of which there are 5 in human cells (Kim et al, 2008; Kurz et al, 2008; Meyer-Schaller et al, 2009; Monda et al, 2013; Keuss et al, 2016). DCUN1D proteins interact with higher affinity to the N-terminally acetylated forms of UBE2F and UBE2M (Scott et al, 2011; Monda et al, 2013). Although each of the 5 DCUN1D proteins appears to interact with most cullin subtypes, specificity may arise through differences in expression and localization, and DCUN1D3 may play a specialized role in sequestering CRL E3 ligase complexes at the cell membrane (Monda et al, 2013; Keuss et al, 2016; Meyer-Schaller et al, 2009; Huang et al, 2014; reviewed in Enchev et al, 2103). Although in this pathway, COMMD proteins and DCUN1D are shown acting sequentially in the activation of the CRL E3 ligase complex, the relationship between these protein families is not totally clear, as DCUN1D proteins have been identified in complexes that also contain the inhibitor CAND1 (Kim et al, 2008; Huang et al, 2014). Target specificity of the CRL1 complex is directed by the nature of the F box substrate recognition protein, of which there are more than 60 in humans. Identified targets of CRL1-containing complexes include signaling molecules, transcriptional regulators and regulators of cell cycle progression, among others (reviewed in Gutierrez and Ronai, 2006; Lipkowitz and Weissman, 2011). CRL1 complexes are also hijacked by a number of viruses, redirecting the ubiquitin ligase complex to target host proteins and in this way promoting viral propagation (reveiwed in Mahon et al, 2014).
R-HSA-8952638 (Reactome) UBE2M transfers NEDD8 to lysine 705 of CUL4A and lysine 859 of CUL4B (Hori et al, 1999; Duda et al, 2008). Neddylation increases the ubiquitination activity of the E3 complex towards its targets, and prevents binding of the CUL4 complex with the CAND1 inhibitor (Hori et al, 1999; Duda et al, 2008). CRL4 complexes ubiquitinate target proteins involved in processes such as cell cycle progression, DNA repair and replication, cell growth and metabolism (reviewed in Hannah and Zhou, 2015; Sang et al, 2015). CRL4 complexes are also hijacked by a number of viruses, redirecting the ubiquitin ligase complex to target host proteins and in this way promoting viral propagation (reveiwed in Mahon et al, 2014). Note that because many of the key CRL4 ubiquitin targets are nuclear, these complexes are depicted in the nucleus. Cytoplasmic targets have also been identified, however (reviewed in Hannah and Zhou, 2015).
R-HSA-8952639 (Reactome) UBE2M is the E2 for CRL complexes containing cullin 1, 2, 3 and 4 (Huang et al, 2009; Monda et al, 2013). Interaction between UBE2M and the CUL4A and 4B E3 complex is facilitated by a DCUN1D (also known as DCNL) scaffold protein, of which there are 5 in human cells (Kim et al, 2008; Kurz et al, 2008; Meyer-Schaller et al, 2009; Monda et al, 2013; Keuss et al, 2016). DCUN1D proteins interact with higher affinity to the N-terminally acetylated forms of UBE2F and UBE2M (Scott et al, 2011; Monda et al, 2013). Although each of the 5 DCUN1D proteins appears to interact with most cullin subtypes, specificity may arise through differences in expression and localization, and DCUN1D3 may play a specialized role in sequestering CRL E3 ligase complexes at the cell membrane (Monda et al, 2013; Keuss et al, 2016; Meyer-Schaller et al, 2009; Huang et al, 2014; reviewed in Enchev et al, 2103). Although in this pathway, COMMD proteins and DCUN1D are shown acting sequentially in the activation of the CRL E3 ligase complex, the relationship between these protein families is not totally clear, as DCUN1D proteins have been identified in complexes that also contain the inhibitor CAND1 (Kim et al, 2008; Huang et al, 2014).
CRL4 complexes ubiquitinate target proteins involved in processes such as cell cycle progression, DNA repair and replication, cell growth and metabolism (reviewed in Hannah and Zhou, 2015; Sang et al, 2015). CRL4 complexes are also hijacked by a number of viruses, redirecting the ubiquitin ligase complex to target host proteins and in this way promoting viral propagation (reviewed in Mahon et al, 2014). Note that because many of the key CRL4 ubiquitin targets are nuclear, these complexes are depicted in the nucleus. Cytoplasmic targets have also been identified, however (reviewed in Hannah and Zhou, 2015).
R-HSA-8955241 (Reactome) CRL complexes consist of a cullin protein (CUL1, 2, 3, 4A, 4B, 5, 7 and 9 in humans) and a RING box protein (RBX1 or 2) in addition to one or more substrate binding proteins that confer substrate specificity to the complex (reviewed in Petroski and Deshaies, 2005; Lipkowitz and Weismann, 2011). CRL complexes can be classes according to their cullin proteins: CRL1 complexes (also called SCF complexes) contain CUL1, CRL2 complexes contain CUL2, CLR complexes contain CUL3, and CLR5 complexes contain CUL5. Cullin-associated NEDD8-dissociated protein 1 (CAND1, TIP120) is a key assembly factor of Cullin E3 RING ubiquitin ligase (CRL) complexes, acting as a substrate receptor exchange factor. CAND1 binds to the inactive, deneddylated CRL complex through the conserved amino-terminal 3 Cullin repeats of the cullin subunit, which are also required for binding of the substrate binding proteins (Zheng et al, 2002a, b; Liu et al 2002; Min et al, 2003; Goldenberg et al, 2004). By disrupting the substrate binding protein interaction interface on the cullin proteins, CAND1 binding destabilizes the CRL complex, allowing exchange of the substrate binding protein (Schmidt et al, 2009; Pierce et al, 2013; Zemla et al, 2013; Wu et al, 2013). Neddylation of the CRL complex results in a conformational change that eliminates the CAND1 binding site, thereby promoting the active CRL ubiquitin ligase complex (Duda et al, 2008; Saha and Deshaies, 2008; Boh et al, 2011; Yu et al, 2015).

R-HSA-8955245 (Reactome) CRL complexes consist of a cullin protein (CUL1, 2, 3, 4A, 4B, 5, 7 and 9 in humans) and a RING box protein (RBX1 or 2) in addition to one or more substrate binding proteins that confer substrate specificity to the complex (reviewed in Petroski and Deshaies, 2005; Lipkowitz and Weismann, 2011). CRL4 complexes contain CUL4A or CUL4B. Cullin-associated NEDD8-dissociated protein 1 (CAND1, TIP120) is a key assembly factor of Cullin E3 RING ubiquitin ligase (CRL) complexes, acting as a substrate receptor exchange factor. CAND1 binds to the inactive, deneddylated CRL complex through the conserved amino-terminal 3 Cullin repeats of the cullin subunit, which are also required for binding of the substrate binding proteins (Zheng et al, 2002a, b; Liu et al 2002; Min et al, 2003; Goldenberg et al, 2004). In this way, CAND1 binding destabilizes the CRL complex, allowing exchange of the substrate binding protein (Schmidt et al, 2009; Pierce et al, 2013). Neddylation of the CRL complex results in a conformational change that eliminates the CAND1 binding site (Duda et al, 2008; Saha and Deshaies, 2008; Boh et al, 2011).
R-HSA-8955285 (Reactome) COMMD1 is a member of a family of 10 copper metabolism MURR1 domain-containing proteins that have pleiotropic roles in copper metabolism, NF kappa beta-mediated transcription, the hypoxic response and electrolyte transport (Burstein et al, 2005; reviewed in Maine and Burstein, 2007). COMMD proteins have differential tissue and expression levels, but appear to have partially overlapping function and form homo- and heterodimers through the shared COMM domain (Burstein et al, 2005). COMMD1 and other family members interact with the cullin subunit of CRL E3 ubiquitin ligase complexes, as well as with CCDC22, a protein implicated in X-linked intellectual disability that may regulate COMMD localization. Together, COMMD proteins and CCDC22 activate the ubiquitin ligase activity of CRL complexes by displacing the CAND1 inhibitor (Burstein et al, 2005; Maine et al, 2007; Mao et al, 2011; Starokadomskyy et al, 2013;Phillips-Krawczak et al, 2015). The specificity of interaction between various COMMD and CUL family members may serve to fine tune the regulation of CRL activation, although these details remain to be determined.
R-HSA-8955289 (Reactome) COMMD1 is a member of a family of 10 copper metabolism MURR1 domain-containing proteins that have pleiotropic roles in copper metabolism, NF kappa beta-mediated transcription, the hypoxic response and electrolyte transport (Burstein et al, 2005; reviewed in Maine and Burstein, 2007). COMMD proteins have differential tissue and expression levels, but appear to have partially overlapping function and form homo- and heterodimers through the shared COMM domain (Burstein et al, 2005). COMMD1 and other family members interact with the cullin subunit of CRL E3 ubiquitin ligase complexes, as well as with CCDC22, a protein implicated in X-linked intellectual disability that may regulate COMMD localization. Together, COMMD proteins and CCDC22 activate the ubiquitin ligase activity of CRL complexes by displacing the CAND1 inhibitor (Burstein et al, 2005; Maine et al, 2007; Mao et al, 2011; Starokadomskyy et al, 2013;Phillips-Krawczak et al, 2015). The specificity of interaction between various COMMD and CUL family members may serve to fine tune the regulation of CRL activation, although these details remain to be determined.
R-HSA-8956025 (Reactome) UBE2M transfers NEDD8 to lysine 1881 of CUL9 (Skaar et al, 2007; Li et al, 2014). Neddylation increases the ubiquitination activity of the E3 complex towards its targets (Hori et al, 1999; Duda et al, 2008). One defined target of CUL9 is BIRC5 (also known as Survivin), which has roles in cellular proliferation, inhibition of apoptosis and maintenance of genome stability (Zhao et al, 2000; Watanabe, 2010). CUL9-mediated ubiquitination of BIRC5 is negatively regulated by the 3M complex, consisting of CUL7, CCDC8 and OBSL1 (Li et al, 2014).
R-HSA-8956026 (Reactome) One defined target of CUL9 ubiquitin ligase is BIRC5 (also known as Survivin), which has roles in cellular proliferation, inhibition of apoptosis and maintenance of genome stability (Zhao et al, 2000; Watanabe, 2010). Deletion of CUL9 leads to polyploidy, abnormal nuclear morphology and DNA damage and is accompanied by an increase in survivin protein levels (Li et al, 2014). CUL9-mediated ubiquitination of BIRC5 is negatively regulated by the 3M complex, consisting of CUL7, CCDC8 and OBSL1 (Li et al, 2014; Yan et al, 2014). This CUL7-dependent inhibition of CUL9 ubiquitin ligase activity is promoted by heterodimerization between CUL7 and CUL9 (Li et al, 2014).
R-HSA-8956031 (Reactome) CUL9 (also known as PARC for p53-associated PARkin-like cytoplasmic protein) is an atypical cullin that has been shown to form a ubiquitin ligase complex with RBX1, although other components of the putative CRL9 complex have not yet been identified (Skaar et al, 2007; Li et al, 2014). CUL9:RBX1 is neddylated in vivo, likely through the UBE2M E2 although this hasn't been directly demonstrated (Skaar et al, 2007).
CUL9 is 60% identical to CUL7, another atypical mammalian cullin family member, but more distantly related to CUL1, 2, 3, 4A,4B and 5. CUL9 and CUL7 have been shown to form a heterodimer in vivo, and both interact with p53 (Skaar et al, 2007; Andrews et al, 2006; Nikolaev et al, 2003). CUL9 ubiquitinates BIRC5 (also known as Survivin), a protein with roles in cellular proliferation and inhibition of apoptosis. CUL9-mediated ubiquitination of BIRC5 is inhibited by the 3M complex, which consists of CUL7, CCDC8 and OBSL1 (Li et al, 2014).
R-HSA-8956040 (Reactome) The COP9 signalosome (also known as CSN) is a highly conserved multi-subunit enzymatic complex that plays a role as the sole CRL ubiquitin ligase deneddylase. Deneddylation decreases ubiquitin ligase activity of CRL complexes, and is required for the sCAND1 binding to the cullin subunit. The CSN is required for stabilization of CRL substrate receptors: without the CSN, CRL complexes are "hyper-active" and promote their own degradation through autoubiquitination. Both the CSN and CAND1 allow remodeling of the ubiquitin ligase complex through exchange of the ubiquitin substrate specific receptors (Cope et al, 2006; Denti et al, 2006; Peth et al, 2007; Schmidt et al, 2009; Enchev et al, 2012; Pierce et al, 2013; Zemla et al, 2013; Wu et al, 2013, reviewed in Wei et al, 2008). Deregulation of the CRL-CSN pathway causes misregulation of numerous important cellular targets and has been implicated in the development of some cancers (reviewed in Gummlich et al, 2013).
R-HSA-8956045 (Reactome) The COP9 signalosome (also known as CSN) is a highly conserved multi-subunit enzymatic complex that plays a role as the sole CRL ubiquitin ligase deneddylase. Deneddylation decreases ubiquitin ligase activity of CRL complexes, and is required for the subsequent binding of CAND1 to the cullin subunit. The CSN is required for stabilization of CRL substrate receptors: without the CSN, CRL complexes are "hyper-active" and promote their own degradation through autoubiquitination. Both the CSN and CAND1 allow remodeling of the ubiquitin ligase complex through exchange of the ubiquitin substrate specific receptors (Cope et al, 2006; Denti et al, 2006; Peth et al, 2007; Schmidt et al, 2009; Enchev et al, 2012; Pierce et al, 2013; Zemla et al, 2013; Wu et al, 2013, reviewed in Wei et al, 2008). Deregulation of the CRL-CSN pathway causes misregulation of numerous important cellular targets and has been implicated in the development of some cancers (reviewed in Gummlich et al, 2013).
R-HSA-8956050 (Reactome) CUL7, CCDC8 and OBSL1 are part of a 3M complex that has roles in maintenace of genome stability and microtubule dynamics (Li et al, 2014; Yan et al, 2014). The 3M complex inhibits CUL9-mediated ubiquitination of BIRC5 through the formation of a CUL9:CUL7 heterodimer (Skaar et al, 2007; Li et al, 2014)
R-HSA-8956099 (Reactome) The best characterized CRL2 substrate binding F-box protein is the von Hippel- Lindau (VHL) tumor suppressor, which targets the alpha subunit of hypoxia inducible factor (HIFalpha) for ubiquitination and degradation through VCP/p97 and the 26 S proteasome (Sufan and Ohh, 2006; Heir et al, 2013; reviewed in Cai and Yang, 2016). UBXN7 is an adapter that binds to neddylated CUL2 and interferes with the ability of the CUL2:EloB:EloC:VHL E3 ubiquitin ligase complex to ubiquitinate HIF alpha, in this way causing accumulation of HIF alpha (Bandau et al, 2012; Den Besten et al, 2012)
R-HSA-8956103 (Reactome) The best characterized CRL2 substrate binding F-box protein is the von Hippel- Lindau (VHL) tumor suppressor, which targets the alpha subunit of hypoxia inducible factor (HIFalpha) for ubiquitination and degradation through VCP/p97 and the 26 S proteasome (Sufan and Ohh, 2006; Heir et al, 2013; reviewed in Cai and Yang, 2016). UBXN7 is an adapter that binds to neddylated CUL2 and interferes with the ability of the CUL2:EloB:EloC:VHL E3 ubiquitin ligase complex to ubiquitinate HIF alpha, in this way causing accumulation of HIF alpha (Bandau et al, 2012; Den Besten et al, 2012)
R-HSA-8956106 (Reactome) VHL is the substrate binding protein of a CUL2-based E3 ubiquitin ligase complex that conjugates ubiquitin to hydroxylated HIF-alpha (Iwai et al. 1999, Kamura et al. 2000, Ohh et al. 2000, Groulx and Lee 2002, Maynard et al. 2003). VHL is predominantly cytosolic and shuttles between the cytosol and the nucleus (Lee et al. 1999, Groulx and Lee 2002). Ubiquitination and degradation of HIF-alpha can occur in both the cytosol and the nucleus (Berra et al. 2001). Upon return to normoxia from hypoxia most ubiquitinated HIF-alpha is nuclear (Groulx and Lee 2002).
R-HSA-8956140 (Reactome) NEDD8 ultimate buster 1 (NUB1) is a negative regulator of the NEDD8 conjugation system. NUB1 interacts with NEDD8 and another ubiquitin-like modifier, UBD (also known as FAT10) to promote their degradation and that of their conjugated proteins (Kito et al, 2001; Kamitani et al, 2001; Hipp et al, 2004; Schmidtke et al, 2006). NUB1 interacts directly with both NEDD8/UBD and with PMSD4, a subunit of the 19S cap of the 26S proteasome, through a ubiquitin-like domain (UBL), and in this way promotes the contact between the proteasome and its substrate (Kito et al, 2001; Kamitani et al, 2001; Hipp et al, 2004; Tanji et al, 2005; Schmidtke et al, 2006; reviewed in Tanaka et al, 2012; Schmidtke et al, 2014). There are two isoforms of NUB1 in human cells that differ by the presence of a 14 amino acid insertion in the NUB1L. NUB1L promotes the degradation of NEDD8 more efficiently than the short isoform (Tanaka et al, 2003).
R-HSA-8956184 (Reactome) NUB1 mediates the 26S proteasome-dependent degradation of NEDD8, UBN (also known as FAT10) and their protein conjugates (Kamitani et al, 2001; Tanji et al, 2005;Schmidtke et al, 2006; reviewed in Tanaka et al, 2012; Schmidtke et al, 2014). Unlike the case for ubiquitin, the NEDD8 moiety also seems to be subject to degradation along with its conjugated proteins.
R-HSA-8956200 (Reactome) DCUN1D3 binds to CRL1 ligase complexes to antagonize their neddylation and activation. DCUN1D3 is unique among the DCUN1D family members in that is N-terminally myristolyated, resulting in plasma membrane localization. Binding of DCUN1D3 to CUL1-containing E3 ligase complexes sequesters the cullin complexes at the plasma membrane, inhibiting their DCUN1D1-mediated neddylation (Huang et al, 2014). Although in this reaction DCUN1D3 is shown binding to cullin E3 ligases in complex with COMMD proteins and CCDC22, DCUN1D3 has also been shown to interact with CAND1 and the precise timing of this sequestration binding event remains to be clarified.
R-HSA-8956234 (Reactome) PUM2 is a sequence-specific RNA binding protein that binds DCUN1D3 mRNA and decreases levels of mature DCUN1D3 protein, likely by promoting mRNA degradation (Galgano et al, 2008; Huang et al, 2014).
RBX1:CUL4:DDB1:DCAFsR-HSA-8955245 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:UBXN7ArrowR-HSA-8956099 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:UBXN7TBarR-HSA-8956106 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:hydroxyPro-HIF-alphaArrowR-HSA-8956103 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:hydroxyPro-HIF-alphaR-HSA-8956106 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5:hydroxyPro-HIF-alphamim-catalysisR-HSA-8956106 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5R-HSA-8956099 (Reactome)
RBX1:NEDD8-CUL2:EloB,C:VHL:COMMDs:CCDC22:DCUN1D1,2,4,5R-HSA-8956103 (Reactome)
UBA3:NAE1R-HSA-8951648 (Reactome)
UBA3:NAE1mim-catalysisR-HSA-8951648 (Reactome)
UBE2D1,2,3:UbiquitinR-HSA-8956106 (Reactome)
UBE2D1,2,3ArrowR-HSA-8956106 (Reactome)
UBXN7R-HSA-8956099 (Reactome)
UCHL3,SENP8:NEDD8(1-88)R-HSA-5690808 (Reactome)
UCHL3,SENP8:NEDD8(1-88)mim-catalysisR-HSA-5690808 (Reactome)
UCHL3,SENP8:NEDD8ArrowR-HSA-5690808 (Reactome)
UCHL3,SENP8:NEDD8R-HSA-8951644 (Reactome)
UCHL3,SENP8ArrowR-HSA-8951644 (Reactome)
UbR-HSA-8956026 (Reactome)
hydroxyPro-HIF-alphaR-HSA-8956103 (Reactome)
ub-BIRC5ArrowR-HSA-8956026 (Reactome)
ub-hydroxyPro-HIF-alpha:VHL:EloB:EloC:NEDD8-CUL2:RBX1:COMMDs:CCDC22:DCUN1D1,2,4,5ArrowR-HSA-8956106 (Reactome)
Personal tools